Document:

EX-10.4

 Exhibit 10.4 

EXECUTION VERSION 
  

					
		  		  	

   
			
		  		  	 Deutsche Bank AG, London Branch
 Winchester
house
 1 Great Winchester St, London EC2N 2DB
 Telephone: 44 20
7545 8000
  
 c/o Deutsche Bank Securities Inc.

60 Wall Street
 New York, NY 10005

Telephone: 212-250-2500

			
		  		  	Internal Reference: 851405

 December 4, 2019 
 To:
Allscripts Healthcare Solutions, Inc. 
 222 Merchandise Mart, Suite 2024 

Chicago, IL 60654 
 Attention: Denis Olis (Chief Financial
Officer); Brian Farley (General Counsel) 
 Telephone No.: 312.386.6700;
312-447-2400 
 Email: dennis.olis@allscripts.com;
legal.notices@allscripts.com 
  

	Re:	 Base Call Option Transaction 

The purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the call option
transaction entered into between Deutsche Bank AG, London Branch (“Dealer”) and Allscripts Healthcare Solutions, Inc. (“Counterparty”) as of the Trade Date specified below (the
“Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. Each party further agrees that this Confirmation together with the Agreement evidence a
complete binding agreement between Counterparty and Dealer as to the subject matter and terms of the Transaction to which this Confirmation relates, and shall supersede all prior or contemporaneous written or oral communications with respect
thereto. 
 The definitions and provisions contained in the 2002 ISDA Equity Derivatives Definitions (the “Equity
Definitions”), as published by the International Swaps and Derivatives Association, Inc. (“ISDA”) are incorporated into this Confirmation. In the event of any inconsistency between the Equity Definitions and this
Confirmation, this Confirmation shall govern. Certain defined terms used herein are based on terms that are defined in the Offering Memorandum dated December 4, 2019 (the “Offering Memorandum”) relating to the 0.875%
Convertible Senior Notes due 2027 (as originally issued by Counterparty, the “Convertible Notes” and each USD 1,000 principal amount of Convertible Notes, a “Convertible Note”) issued by Counterparty in an aggregate
initial principal amount of USD 200,000,000 (as increased by up to an aggregate principal amount of USD 30,000,000 if and to the extent that the Initial Purchasers (as defined herein) exercise their option to purchase additional Convertible Notes
pursuant to the Purchase Agreement (as defined herein)) pursuant to an Indenture to be dated December 9, 2019 between Counterparty and U.S. Bank National Association, as trustee (the “Indenture”). In the event of any 

 

			
	 Chairman of the Supervisory Board: Paul Achleitner.

Management Board: Christian Sewing (Chairman), Karl von Rohr, Frank Kuhnke, Stuart Lewis, James von Moltke, Werner Steinmüller.

 
 Deutsche Bank AG is authorised under German Banking Law (competent
authority: European Central Bank and the BaFin, Germany’s Federal Financial Supervisory Authority) and, in the United Kingdom, by the Prudential Regulation Authority. It is subject to supervision by the European Central Bank and by the BaFin,
and is subject to limited regulation in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority.
	  	 Deutsche Bank AG is a joint stock corporation with limited liability incorporated in the Federal
Republic of Germany, Local Court of Frankfurt am Main, HRB No. 30 000; Branch Registration in England and Wales BR000005 and Registered Address:
 Winchester
House, 1 Great Winchester Street, London EC2N 2DB. Deutsche Bank AG, London Branch is a member of the London Stock Exchange. (Details about the extent of our authorisation and regulation in the United Kingdom are available on request or from
www.db.com/en/content/eu_disclosures.htm)

 inconsistency between the terms defined in the Offering Memorandum, the Indenture and this Confirmation,
this Confirmation shall govern. The parties acknowledge that this Confirmation is entered into on the date hereof with the understanding that (i) definitions set forth in the Indenture which are also defined herein by reference to the Indenture
and (ii) sections of the Indenture that are referred to herein will conform to the descriptions thereof in the Offering Memorandum. If any such definitions in the Indenture or any such sections of the Indenture differ from the descriptions
thereof in the Offering Memorandum, the descriptions thereof in the Offering Memorandum will govern for purposes of this Confirmation. The parties further acknowledge that the Indenture section numbers used herein are based on the draft of the
Indenture last reviewed by Dealer as of the date of this Confirmation, and if any such section numbers are changed in the Indenture as executed, the parties will amend this Confirmation in good faith to preserve the intent of the parties. Subject to
the foregoing, references to the Indenture herein are references to the Indenture as in effect on the date of its execution, and if the Indenture is amended or supplemented following such date (other than any amendment or supplement
(x) pursuant to Section 10.01(h) of the Indenture that, as determined by the Calculation Agent, conforms the Indenture to the description of Convertible Notes in the Offering Memorandum or (y) pursuant to Section 14.07 of the
Indenture, subject, in the case of this clause (y), to the second paragraph under “Method of Adjustment” in Section 3 of this Confirmation), any such amendment or supplement will be disregarded for purposes of this Confirmation (other
than as provided in Section 9(i)(iii) of this Confirmation) unless the parties agree otherwise in writing. 
 DEUTSCHE BANK AG,
LONDON BRANCH IS NOT REGISTERED AS A BROKER DEALER UNDER THE U.S. SECURITIES EXCHANGE ACT OF 1934. DEUTSCHE BANK SECURITIES INC. (“DBSI”) HAS ACTED SOLELY AS AGENT IN CONNECTION WITH THE TRANSACTION AND HAS NO OBLIGATION, BY WAY OF
ISSUANCE, ENDORSEMENT, GUARANTEE OR OTHERWISE WITH RESPECT TO THE PERFORMANCE OF EITHER PARTY UNDER THE TRANSACTION. AS SUCH, ALL DELIVERY OF FUNDS, ASSETS, NOTICES, DEMANDS AND COMMUNICATIONS OF ANY KIND RELATING TO THE TRANSACTION BETWEEN DEUTSCHE
BANK AG, LONDON BRANCH, AND COUNTERPARTY SHALL BE TRANSMITTED EXCLUSIVELY THROUGH DEUTSCHE BANK SECURITIES INC. DEUTSCHE BANK AG, LONDON BRANCH IS NOT A MEMBER OF THE SECURITIES INVESTOR PROTECTION CORPORATION (SIPC). 

Each party is hereby advised, and each such party acknowledges, that the other party has engaged in, or refrained from engaging in,
substantial financial transactions and has taken other material actions in reliance upon the parties’ entry into the Transaction to which this Confirmation relates on the terms and conditions set forth below. 

1. This Confirmation evidences a complete and binding agreement between Dealer and Counterparty as to the terms of the Transaction to which this Confirmation
relates. This Confirmation shall supplement, form a part of, and be subject to an agreement in the form of the 2002 ISDA Master Agreement (the “Agreement”) as if Dealer and Counterparty had executed an agreement in such form (but
without any Schedule except for (i) the election of the laws of the State of New York as the governing law (without reference to choice of law doctrine) and (ii) the election that the “Cross Default” provisions of
Section 5(a)(vi) of the Agreement will apply to Dealer as if (a) the phrase “, or becoming capable at such time of being declared,” were deleted from Section 5(a)(vi)(1) of the Agreement, (b) the “Threshold
Amount” with respect to Dealer were three percent of the shareholders’ equity of Deutsche Bank AG, (c) the following language were added to the end of Section 5(a)(vi): “Notwithstanding the foregoing, a default under
subsection (2) hereof shall not constitute an Event of Default if (x) the default was caused solely by error or omission of an administrative or operational nature; (y) funds were available to enable the party to make the payment when
due; and (z) the payment is made within two Local Business Days of such party’s receipt of written notice of its failure to pay.”; and (d) the term “Specified Indebtedness” had meaning specified in Section 14 of
the Agreement, except that such term shall not include obligations in respect of deposits received in the ordinary course of a party’s banking business) on the Trade Date. In the event of any inconsistency between provisions of the Agreement
and this Confirmation, this Confirmation will prevail for the purpose of the Transaction to which this Confirmation relates. The parties hereby agree that no transaction other than the Transaction to which this Confirmation relates shall be governed
by the Agreement. 

  
 2 

 2. The terms of the particular Transaction to which this Confirmation relates are as follows: 

 

			
	 General Terms.
	  	
		
	 Trade Date:
	  	December 4, 2019
		
	 Effective Date:
	  	The second Exchange Business Day immediately prior to the Premium Payment Date
		
	 Option Style:
	  	“Modified American”, as described under “Procedures for Exercise” below
		
	 Option Type:
	  	Call
		
	 Buyer:
	  	Counterparty
		
	 Seller:
	  	Dealer
		
	 Shares:
	  	The common stock of Counterparty, par value USD 0.01 per share (Exchange symbol “MDRX”).
		
	 Number of Options:
	  	200,000. For the avoidance of doubt, the Number of Options shall be reduced by any Options exercised by Counterparty. In no event will the Number of Options be less than zero.
		
	 Applicable Percentage:
	  	20%
		
	 Option Entitlement:
	  	A number equal to the product of the Applicable Percentage and 75.0962.
		
	 Strike Price:
	  	USD 13.3163
		
	 Cap Price:
	  	USD 17.5875
		
	 Premium:
	  	USD 3,160,000
		
	 Premium Payment Date:
	  	December 9, 2019
		
	 Exchange:
	  	The NASDAQ Global Select Market
		
	 Related Exchange(s):
	  	All Exchanges
		
	 Excluded Provisions:
	  	Section 14.03 and Section 14.04(h) of the Indenture.
		
	 Procedures for Exercise.
	  	
		
	 Conversion Date:
	  	With respect to any conversion of a Convertible Note (other than any conversion of Convertible Notes “in connection with” a “Make-Whole Fundamental Change” (as such phrase or term, as the case may be, is used or
defined in the Indenture) (a “Make-Whole Conversion”) or any conversion of Convertible Notes (other than a Make-Whole Conversion) with a Conversion Date occurring prior to the Free Convertibility Date (an “Early
Conversion”) to which, in each case, the provisions of Section 9(i)(i) of this Confirmation shall apply), the date on which the Holder (as such term is defined in the Indenture) of such Convertible Note satisfies all of the
requirements for conversion thereof as set forth in Section 14.02(b) of the Indenture; provided that if Counterparty has not delivered to Dealer a related Notice of Exercise, then in no event shall a Conversion Date be deemed to occur
hereunder (and no Option shall be exercised or deemed to be exercised hereunder) with respect to any surrender of a Convertible Note for conversion in respect of which Counterparty has elected to designate a financial institution for exchange in
lieu of conversion of such Convertible Note pursuant to Section 14.12 of the Indenture.

  
 3 

			
	 Free Convertibility Date:
	  	July 1, 2026
		
	 Expiration Time:
	  	The Valuation Time
		
	 Expiration Date:
	  	January 1, 2027, subject to earlier exercise.
		
	 Multiple Exercise:
	  	Applicable, as described under “Automatic Exercise” below.
		
	 Automatic Exercise:
	  	 Notwithstanding Section 3.4 of the Equity Definitions, on each Conversion Date occurring on or after the Free Convertibility Date, in
respect of which a Notice of Conversion that is effective as to Counterparty has been delivered by the relevant converting Holder, a number of Options equal to the number of Convertible Notes in denominations of USD 1,000 as to which such Conversion
Date has occurred shall be deemed to be automatically exercised; provided that such Options shall be exercised or deemed exercised only if Counterparty has provided a Notice of Exercise to Dealer in accordance with “Notice of
Exercise” below.
  
 Notwithstanding the foregoing, in no event shall the number of
Options that are exercised or deemed exercised hereunder exceed the Number of Options.

		
	 Notice of Exercise:
	  	Notwithstanding anything to the contrary in the Equity Definitions or under “Automatic Exercise” above, in order to exercise any Options relating to Convertible Notes with a Conversion Date occurring on or after the Free
Convertibility Date, Counterparty must notify Dealer in writing before 5:00 p.m. (New York City time) on the Scheduled Valid Day immediately preceding the Expiration Date specifying the number of such Options; provided that if the Relevant
Settlement Method for such Options is (x) Net Share Settlement and the Specified Cash Amount (as defined below) is not USD 1,000, (y) Cash Settlement or (z) Combination Settlement, Dealer shall have received a separate notice (the
“Notice of Final Settlement Method”) in respect of all such Convertible Notes before 5:00 p.m. (New York City time) on the Free Convertibility Date specifying (1) the Relevant Settlement Method for such Options, and
(2) if the settlement method for the related Convertible Notes is not Settlement in Shares or Settlement in Cash (each as defined below), the fixed amount of cash per Convertible Note that Counterparty has elected to deliver to Holders (as such
term is defined in the Indenture) of the related Convertible Notes (the “Specified Cash Amount”). Counterparty acknowledges its responsibilities under applicable securities laws, and in particular Section 9 and
Section 10(b) of the Exchange Act (as defined below) and the rules and regulations thereunder, in respect of any election of a settlement method with respect to the Convertible Notes.

  
 4 

			
	 Valuation Time:
	  	At the close of trading of the regular trading session on the Exchange; provided that if the principal trading session is extended, the Calculation Agent shall determine the Valuation Time in its reasonable
discretion.
		
	 Market Disruption Event:
	  	 Section 6.3(a) of the Equity Definitions is hereby replaced in its entirety by the following:

 
 “‘Market Disruption Event’ means, in respect of a Share, (i) a failure by
the primary United States national or regional securities exchange or market on which the Shares are listed or admitted for trading to open for trading during its regular trading session or (ii) the occurrence or existence prior to 1:00 p.m.
(New York City time) on any Scheduled Valid Day for the Shares for more than one half-hour period in the aggregate during regular trading hours of any suspension or limitation imposed on trading (by reason of movements in price exceeding limits
permitted by the relevant stock exchange or otherwise) in the Shares or in any options contracts or futures contracts relating to the Shares.”

		
	 Settlement Terms.
	  	
		
	 Settlement Method:
	  	For any Option, Net Share Settlement; provided that if the Relevant Settlement Method set forth below for such Option is not Net Share Settlement, then the Settlement Method for such Option shall be such Relevant Settlement
Method, but only if Counterparty shall have notified Dealer of the Relevant Settlement Method in the Notice of Final Settlement Method for such Option.
		
	 Relevant Settlement Method:
	  	In respect of any Option:
		
		  	(i) if Counterparty has elected to settle its conversion obligations in respect of the related Convertible Note (A) entirely in Shares pursuant to Section 14.02(a)(iv)(A) of the Indenture (together with cash in lieu of
fractional Shares) (such settlement method, “Settlement in Shares”), (B) in a combination of cash and Shares pursuant to Section 14.02(a)(iv)(C) of the Indenture with a Specified Cash Amount less than USD 1,000 (such
settlement method, “Low Cash Combination Settlement”) or (C) in a combination of cash and Shares pursuant to Section 14.02(a)(iv)(C) of the Indenture with a Specified Cash Amount equal to USD 1,000, then, in each case, the
Relevant Settlement Method for such Option shall be Net Share Settlement;
		
		  	(ii) if Counterparty has elected to settle its conversion obligations in respect of the related Convertible Note in a combination of cash and Shares pursuant to Section 14.02(a)(iv)(C) of the Indenture with a Specified Cash Amount
greater than USD 1,000, then the Relevant Settlement Method for such Option shall be Combination Settlement; and

  
 5 

							
		 		  	(iii) if Counterparty has elected to settle its conversion obligations in respect of the related Convertible Note entirely in cash pursuant to Section 14.02(a)(iv)(B) of the Indenture (such settlement method,
“Settlement in Cash”), then the Relevant Settlement Method for such Option shall be Cash Settlement.
			
		 	Net Share Settlement:	  	 If Net Share Settlement is applicable to any Option exercised or deemed exercised hereunder, Dealer will deliver to Counterparty,
on the relevant Settlement Date for each such Option, a number of Shares (the “Net Share Settlement Amount”) equal to the sum, for each Valid Day during the Settlement Averaging Period for each such Option, of (i) (a)
the Daily Option Value for such Valid Day, divided by (b) the Relevant Price on such Valid Day, divided by (ii) the number of Valid Days in the Settlement Averaging Period; provided that in no event shall the Net Share
Settlement Amount for any Option exceed a number of Shares equal to the Applicable Limit for such Option divided by the Applicable Limit Price on the Settlement Date for such Option.

 
 Dealer will pay cash in lieu of delivering any fractional Shares to be delivered with
respect to any Net Share Settlement Amount valued at the Relevant Price for the last Valid Day of the Settlement Averaging Period.

			
	                	 	Combination Settlement:	  	If Combination Settlement is applicable to any Option exercised or deemed exercised hereunder, Dealer will pay or deliver, as the case may be, to Counterparty, on the relevant Settlement Date for each such
Option:
			
		 		  	 (i) cash (the “Combination Settlement Cash Amount”)
equal to the sum, for each Valid Day during the Settlement Averaging Period for such Option, of (A) an amount (the “Daily Combination Settlement Cash Amount”) equal to the lesser of (1) the product of (x) the
Applicable Percentage and (y) the Specified Cash Amount minus USD 1,000 and (2) the Daily Option Value, divided by (B) the number of Valid Days in the Settlement Averaging Period; provided that if the calculation
in clause (A) above results in zero or a negative number for any Valid Day, the Daily Combination Settlement Cash Amount for such Valid Day shall be deemed to be zero; and

			
		 		  	 (ii)  Shares (the “Combination Settlement Share
Amount”) equal to the sum, for each Valid Day during the Settlement Averaging Period for such Option, of a number of Shares for such Valid Day (the “Daily Combination Settlement Share Amount”) equal to
(A) (1) the Daily Option Value on such Valid Day minus the Daily Combination Settlement Cash Amount for such Valid Day, divided by (2) the Relevant Price on such Valid Day, divided by (B) the number of Valid Days
in the Settlement Averaging Period; provided that if the calculation in sub-clause (A)(1) above results in zero or a negative number for any Valid Day, the Daily Combination Settlement Share Amount for
such Valid Day shall be deemed to be zero;

  
 6 

					
	                	 		  	provided that in no event shall the sum of (x) the Combination Settlement Cash Amount for any Option and (y) the Combination Settlement Share Amount for such Option multiplied by the Applicable Limit Price on the
Settlement Date for such Option, exceed the Applicable Limit for such Option.
			
		 		  	Dealer will pay cash in lieu of delivering any fractional Shares to be delivered with respect to any Combination Settlement Share Amount valued at the Relevant Price for the last Valid Day of the Settlement Averaging
Period.
			
		 	Cash Settlement:	  	If Cash Settlement is applicable to any Option exercised or deemed exercised hereunder, in lieu of Section 8.1 of the Equity Definitions, Dealer will pay to Counterparty, on the relevant Settlement Date for each such Option, an
amount of cash (the “Cash Settlement Amount”) equal to the sum, for each Valid Day during the Settlement Averaging Period for such Option, of (i) the Daily Option Value for such Valid Day, divided by (ii) the number
of Valid Days in the Settlement Averaging Period.
			
		 	Daily Option Value:	  	For any Valid Day, an amount equal to (i) the Option Entitlement on such Valid Day, multiplied by (ii) (A) the lesser of the Relevant Price on such Valid Day and the Cap Price, less (B) the Strike Price
on such Valid Day; provided that if the calculation contained in clause (ii) above results in a negative number, the Daily Option Value for such Valid Day shall be deemed to be zero. In no event will the Daily Option Value be less than
zero.
			
		 	Applicable Limit:	  	For any Option, an amount of cash equal to the Applicable Percentage multiplied by the excess of (i) the aggregate of (A) the amount of cash, if any, paid to the Holder of the related Convertible Note upon
conversion of such Convertible Note and (B) the number of Shares, if any, delivered to the Holder of the related Convertible Note upon conversion of such Convertible Note multiplied by the Applicable Limit Price on the Settlement Date
for such Option, over (ii) USD 1,000.
			
		 	Applicable Limit Price:	  	On any day, the opening price as displayed under the heading “Op” on Bloomberg page MDRX <equity> (or any successor thereto).
			
		 	Valid Day:	  	A Trading Day (as defined in the Indenture for purposes of determining amounts due upon conversion of the Convertible Notes).
			
		 	Scheduled Valid Day:	  	A Scheduled Trading Day (as defined in the Indenture).
			
		 	Business Day:	  	Any day other than a Saturday, a Sunday or a day on which the Federal Reserve Bank of New York is authorized or required by law or executive order to close or be closed.

  
 7 

					
	                	 	Relevant Price:	  	On any Valid Day, the per Share volume-weighted average price as displayed under the heading “Bloomberg VWAP” on Bloomberg page MDRX <equity> AQR (or its equivalent successor if such page is not available) in respect
of the period from the scheduled opening time of the Exchange to the Scheduled Closing Time of the Exchange on such Valid Day (or if such volume-weighted average price is unavailable, the market value of one Share on such Valid Day, as determined by
the Calculation Agent using, if practicable, a volume-weighted average method). The Relevant Price will be determined without regard to after-hours trading or any other trading outside of the regular trading session trading hours.
			
		 	Settlement Averaging Period:	  	For any Option, the 50 consecutive Valid Days commencing on, and including, the 51st Scheduled Valid Day immediately prior to the Expiration Date; provided that if the
Notice of Final Settlement Method for such Option specifies that Settlement in Shares or Low Cash Combination Settlement applies to the related Convertible Note, the Settlement Averaging Period shall be the 100 consecutive Valid Days commencing on,
and including, the 101st Scheduled Valid Day immediately prior to the Expiration Date.
			
		 	Settlement Date:	  	For any Option, the second Business Day immediately following the final Valid Day of the Settlement Averaging Period for such Option.
			
		 	Settlement Currency:	  	USD
			
		 	Other Applicable Provisions:	  	The provisions of Sections 9.1(c), 9.8, 9.9 and 9.11 of the Equity Definitions will be applicable, except that all references in such provisions to “Physically-settled” shall be read as references to “Share
Settled”. “Share Settled” in relation to any Option means that Net Share Settlement or Combination Settlement is applicable to that Option.
			
		 	Representation and Agreement:	  	Notwithstanding anything to the contrary in the Equity Definitions (including, but not limited to, Section 9.11 thereof), the parties acknowledge that (i) any Shares delivered to Counterparty shall be, upon delivery,
subject to restrictions and limitations arising from Counterparty’s status as issuer of the Shares under applicable securities laws, (ii) Dealer may deliver any Shares required to be delivered hereunder in certificated form in lieu of
delivery through the Clearance System and (iii) any Shares delivered to Counterparty may be “restricted securities” (as defined in Rule 144 under the Securities Act of 1933, as amended (the “Securities
Act”)).

  
 8 

	3.	 Additional Terms applicable to the Transaction. 

Adjustments applicable to the Transaction: 
  

					
	                	 	Potential Adjustment Events:	  	Notwithstanding Section 11.2(e) of the Equity Definitions, a “Potential Adjustment Event” means an occurrence of any event or condition, as set forth in any
			
	                	 		  	Dilution Adjustment Provision, that would result in an adjustment under the Indenture to the “Conversion Rate”, the composition of a “unit of Reference Property”, to any “Last Reported Sale Price”, any
“Daily VWAP”, any “Daily Conversion Value” or any “Daily Settlement Amount” (each as defined in the Indenture). For the avoidance of doubt, Dealer shall not have any delivery or payment obligation hereunder, and no
adjustment shall be made to the terms of the Transaction, on account of (x) any distribution of cash, property or securities by Counterparty to holders of the Convertible Notes (upon conversion or otherwise) or (y) any other transaction in
which holders of the Convertible Notes are entitled to participate, in each case, in lieu of an adjustment under the Indenture of the type referred to in the immediately preceding sentence (including, without limitation, pursuant to the fourth
sentence of the first paragraph of Section 14.04(c) of the Indenture or the fourth sentence of Section 14.04(d) of the Indenture).
			
		 	Method of Adjustment:	  	Calculation Agent Adjustment, which means that, notwithstanding Section 11.2(c) of the Equity Definitions, upon any Potential Adjustment Event, the Calculation Agent shall make a corresponding adjustment to any one or more of
the Strike Price, Number of Options, Option Entitlement and any other variable relevant to the exercise, settlement or payment for the Transaction, in each case, to the extent an analogous adjustment is required to be made under the
Indenture.
			
		 		  	Notwithstanding the foregoing and “Consequences of Merger Events / Tender Offers” below:
			
		 		  	 (i) if the Calculation Agent in good faith disagrees with any adjustment to the Convertible
Notes that involves an exercise of discretion by Counterparty or its board of directors (including, without limitation, pursuant to Section 14.05 of the Indenture, Section 14.07 of the Indenture or any supplemental indenture entered into
thereunder or in connection with any proportional adjustment or the determination of the fair value of any securities, property, rights or other assets), then in each such case, the Calculation Agent will determine the adjustment to be made to any
one or more of the Strike Price, Number of Options, Option Entitlement and any other variable relevant to the exercise, settlement or payment for the Transaction in a commercially reasonable manner; provided that, notwithstanding the
foregoing, if any Potential Adjustment Event occurs during the Settlement Averaging Period but no adjustment was made to any Convertible Note under the Indenture because the relevant Holder (as such term is defined in the Indenture) was deemed to be
a record owner of the underlying Shares on the related Conversion Date, then the Calculation Agent shall make an adjustment, as determined by it, to the terms hereof in order to account for such Potential Adjustment Event;

  
 9 

			
		  	 (ii)  in connection with any Potential Adjustment Event as a result of an event or
condition set forth in Section 14.04(b) of the Indenture or Section 14.04(c) of the Indenture where, in either case, the period for determining “Y” (as such term is used in Section 14.04(b) of the Indenture) or “SP0 ” (as such term is used in Section 14.04(c) of the Indenture), as the case may be, begins before Counterparty has publicly announced the event or condition giving rise to such Potential
Adjustment Event, then the Calculation Agent shall have the right to adjust any variable relevant to the exercise, settlement or payment for the Transaction as appropriate to reflect the costs (including, but not limited to, hedging mismatches and
market losses) and expenses incurred by Dealer in connection with its hedging activities as a result of such event or condition not having been publicly announced prior to the beginning of such period; and

		
		  	 (iii)  if any Potential Adjustment Event is declared and (a) the event or
condition giving rise to such Potential Adjustment Event is subsequently amended, modified, cancelled or abandoned, (b) the “Conversion Rate” (as defined in the Indenture) is otherwise not adjusted at the time or in the manner contemplated
by the relevant Dilution Adjustment Provision based on such declaration or (c) the “Conversion Rate” (as defined in the Indenture) is adjusted as a result of such Potential Adjustment Event and subsequently re-adjusted (each of clauses (a), (b) and (c), a “Potential Adjustment Event Change”) then, in each case, the Calculation Agent shall have the right to adjust any variable relevant to the
exercise, settlement or payment for the Transaction as appropriate to reflect the costs (including, but not limited to, hedging mismatches and market losses) and expenses incurred by Dealer in connection with its hedging activities as a result of
such Potential Adjustment Event Change.

		
	 Dilution Adjustment Provisions:
	  	Sections 14.04 (a), (b), (c), (d) and (e) and Section 14.05 of the Indenture.
	
	Extraordinary Events applicable to the Transaction:
		
	 Merger Events:
	  	Applicable; provided that notwithstanding Section 12.1(b) of the Equity Definitions, a “Merger Event” means the occurrence of any event or condition set forth in the definition of “Merger Event” in
Section 14.07(a) of the Indenture.

  
 10 

			
	Tender Offers:	  	Applicable; provided that notwithstanding Section 12.1(d) of the Equity Definitions, a “Tender Offer” means the occurrence of any event or condition set forth in Section 14.04(e) of the Indenture.
		
	Consequences of Merger Events/	  	
	Tender Offers:	  	Notwithstanding Section 12.2 and Section 12.3 of the Equity Definitions, upon the occurrence of a Merger Event or a Tender Offer, the Calculation Agent shall make a corresponding adjustment in respect of any adjustment
under the Indenture to any one or more of the nature of the Shares (in the case of a Merger Event), Strike Price, Number of Options, Option Entitlement and any other variable relevant to the exercise, settlement or payment for the Transaction,
subject to the second paragraph under “Method of Adjustment”; provided, however, that such adjustment shall be made without regard to any adjustment to the Conversion Rate pursuant to any Excluded Provision; provided
further that if, with respect to a Merger Event or a Tender Offer, (i) the consideration for the Shares includes (or, at the option of a holder of Shares, may include) shares of an entity or person that is not a corporation or is not
organized under the laws of the United States, any State thereof or the District of Columbia or (ii) the Counterparty to the Transaction following such Merger Event or Tender Offer will not be a corporation organized under the laws of the
United States, any State thereof or the District of Columbia, then, in either case, Cancellation and Payment (Calculation Agent Determination) may apply at Dealer’s sole election; provided further that, for the avoidance of doubt,
adjustments shall be made pursuant to the provisions set forth above regardless of whether any Merger Event or Tender Offer gives rise to an Early Conversion or a Make-Whole Conversion.
		
	Consequences of Announcement Events:	  	Modified Calculation Agent Adjustment as set forth in Section 12.3(d) of the Equity Definitions; provided that, in respect of an Announcement Event, (x) references to “Tender Offer” shall be replaced by
references to “Announcement Event” and references to “Tender Offer Date” shall be replaced by references to “date of such Announcement Event”, (y) the phrase “exercise, settlement, payment or any other terms of the
Transaction (including, without limitation, the spread)” shall be replaced with the phrase “Cap Price (provided that in no event shall the Cap Price be less than the Strike Price)”, and (z) for the avoidance of doubt, the
Calculation Agent shall determine whether the relevant Announcement Event has had an economic effect on the Transaction (and, if so, shall adjust the Cap Price accordingly) on one or more occasions on or after the date of the Announcement Event up
to, and including, the Expiration Date, any Early Termination Date and/or any other date of cancellation, it being understood that any adjustment in respect of an Announcement Event shall take into account any earlier adjustment relating to the same
Announcement Event. An Announcement Event shall be an “Extraordinary Event” for purposes of the Equity Definitions, to which Article 12 of the Equity Definitions is applicable.

  
 11 

			
	Announcement Event:	  	(i) The public announcement by any entity of (x) any transaction or event that, if completed, would constitute a Merger Event or Tender Offer, (y) any potential acquisition by Issuer and/or its subsidiaries where the
aggregate consideration exceeds 25% of the market capitalization of Issuer as of the date of such announcement (an “Acquisition Transaction”) or (z) the intention to enter into a Merger Event or Tender Offer or an Acquisition
Transaction, (ii) the public announcement by Issuer of an intention to solicit or enter into, or to explore strategic alternatives or other similar undertaking that may include, a Merger Event or Tender Offer or an Acquisition Transaction or
(iii) any subsequent public announcement by any entity of a change to a transaction or intention that is the subject of an announcement of the type described in clause (i) or (ii) of this sentence (including, without limitation, a new
announcement, whether or not by the same party, relating to such a transaction or intention or the announcement of a withdrawal from, or the abandonment or discontinuation of, such a transaction or intention), as determined by the Calculation Agent.
For the avoidance of doubt, the occurrence of an Announcement Event with respect to any transaction or intention shall not preclude the occurrence of a later Announcement Event with respect to such transaction or intention. For purposes of this
definition of “Announcement Event,” (A) “Merger Event” shall mean such term as defined under Section 12.1(b) of the Equity Definitions (but, for the avoidance of doubt, the remainder of the definition of “Merger
Event” in Section 12.1(b) of the Equity Definitions following the definition of “Reverse Merger” therein shall be disregarded) and (B) “Tender Offer” shall mean such term as defined under Section 12.1(d) of the
Equity Definitions.
		
	Nationalization, Insolvency or Delisting:	  	Cancellation and Payment (Calculation Agent Determination); provided that, in addition to the provisions of Section 12.6(a)(iii) of the Equity Definitions, it will also constitute a Delisting if the Exchange is located
in the United States and the Shares are not immediately re-listed, re-traded or re-quoted on any of the New York Stock Exchange,
The NASDAQ Global Select Market or The NASDAQ Global Market (or their respective successors); if the Shares are immediately re-listed, re-traded or re-quoted on any of the New York Stock Exchange, The NASDAQ Global Select Market or The NASDAQ Global Market (or their respective successors), such exchange or quotation system shall thereafter be deemed to be the
Exchange.

  
 12 

					
		 	Additional Disruption Events:	  	
			
		 	Change in Law:	  	Applicable; provided that Section 12.9(a)(ii) of the Equity Definitions is hereby amended by (i) replacing the phrase “the interpretation” in the third line thereof with the phrase “, or public
announcement of, the formal or informal interpretation”, (ii) replacing the word “Shares” where it appears in clause (X) thereof with the words “Hedge Position” and (iii) replacing the parenthetical beginning after
the word “regulation” in the second line thereof the words “(including, for the avoidance of doubt and without limitation, (x) any tax law or (y) adoption, effectiveness or promulgation of new regulations authorized or
mandated by existing statute)”.
			
		 	Failure to Deliver:	  	Applicable
			
		 	Hedging Disruption:	  	Applicable; provided that:
			
		 		  	 (i) Section 12.9(a)(v) of the Equity Definitions is hereby amended by
(a) inserting the following words at the end of clause (A) thereof: “in the manner contemplated by the Hedging Party on the Trade Date” and (b) inserting the following two phrases at the end of such Section:

			
		 		  	 “For the avoidance of doubt, the term “equity price risk” shall be deemed to include, but shall not be
limited to, stock price and volatility risk. And, for the further avoidance of doubt, any such transactions or assets referred to in phrases (A) or (B) above must be available on commercially reasonable pricing terms.”; and

			
		 		  	 (ii)  Section 12.9(b)(iii) of the Equity Definitions is hereby amended by
inserting in the third line thereof, after the words “to terminate the Transaction”, the words “or a portion of the Transaction affected by such Hedging Disruption”.

			
		 	Hedging Party:	  	For all applicable Additional Disruption Events, Dealer.
			
		 	Determining Party:	  	For all applicable Extraordinary Events, Dealer.
			
		 	Non-Reliance:	  	Applicable
			
		 	Agreements and Acknowledgments	  	
		 	Regarding Hedging Activities:	  	Applicable
			
		 	Additional Acknowledgments:	  	Applicable
		
	 4.  Calculation Agent.
	  	Dealer
		
	 5.  Account Details.
	  	
		
	 (a)   Account for payments to Counterparty:

 
 Bank: JPMorgan Chase

Bank Address: Chicago, IL

ABA#: 021000021 (wire only)

Acct No.: 790378764

Account Name: Allscripts Healthcare, LLC
	  	

  
 13 

 Text/Ref: Capped Call for 2019 Convertible Issuance 

Account for delivery of Shares to Counterparty: 

To be separately provided. 

Account for payments to Dealer: 

Bank: Bank of New York 
 SWIFT:
IRVTUS3N 
 ABA#: 021-000-018 

Acct Name: Deutsche Bank Securities Inc. 

Acct No.: 8900327634 
  

	6.	 Offices. 

 

	 	(a)	 The Office of Counterparty for the Transaction is: Inapplicable, Counterparty is not a Multibranch Party.

  

	 	(b)	 The Office of Dealer for the Transaction is: London 

 

	7.	 Notices. 

 

	 	(a)	 Address for notices or communications to Counterparty: 

Allscripts Healthcare Solutions, Inc. 

222 Merchandise Mart, Suite 2024 

Chicago, IL 60654 
  

					
		 	Attention:	  	 Denis Olis (Chief Financial Officer)

		 		  	 Brian Farley (General Counsel)

		 	Telephone No.: 312-386-6700; 312-447-2400
		 	Email: dennis.olis@allscripts.com; legal.notices@allscripts.com

  

	 	(b)	 Address for notices or communications to Dealer: 

 

					
		 	To:	  	 Deutsche Bank AG, London Branch

		 		  	 c/o Deutsche Bank Securities Inc.

		 		  	 60 Wall Street

		 		  	 New York, NY 10005

		 	Attention:	  	 Faiz Khan

		 		  	 Michael Fortino

		 	Telephone:	  	
212-250-0668

		 		  	
212-250-6734

		 	Email:	  	 faiz.khan@db.com; michael.fortino@db.com;

		 		  	 equity-linked.notifications@list.db.com

  

	8.	 Representations and Warranties of Counterparty. 

Each of the representations and warranties of Counterparty set forth in Section 3 of the Purchase Agreement (the “Purchase
Agreement”) dated as of December 4, 2019, among Counterparty and J.P. Morgan Securities LLC and Wells Fargo Securities, LLC as representatives of the Initial Purchasers party thereto (the “Initial Purchasers”), are
true and correct and are hereby deemed to be repeated to Dealer as if set forth herein. Counterparty hereby further represents and warrants to Dealer on the date hereof and on and as of the Premium Payment Date that: 

 

	 	(a)	 Counterparty has all necessary corporate power and authority to execute, deliver and perform its obligations in
respect of the Transaction; such execution, delivery and performance have been duly authorized by all necessary corporate action on Counterparty’s part; and this Confirmation has been duly and validly executed and delivered by Counterparty and
constitutes its valid and 

  
 14 

	 	binding obligation, enforceable against Counterparty in accordance with its terms, subject to applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and similar laws affecting
creditors’ rights and remedies generally, and subject, as to enforceability, to general principles of equity, including principles of commercial reasonableness, good faith and fair dealing (regardless of whether enforcement is sought in a
proceeding at law or in equity) and except that rights to indemnification and contribution hereunder may be limited by federal or state securities laws or public policy relating thereto. 

 

	 	(b)	 Neither the execution and delivery of this Confirmation nor the incurrence or performance of obligations of
Counterparty hereunder will conflict with or result in a breach of the certificate of incorporation or by-laws (or any equivalent documents) of Counterparty, or any applicable law or regulation, or any order,
writ, injunction or decree of any court or governmental authority or agency, or any agreement or instrument to which Counterparty or any of its subsidiaries is a party or by which Counterparty or any of its subsidiaries is bound or to which
Counterparty or any of its subsidiaries is subject, or constitute a default under, or result in the creation of any lien under, any such agreement or instrument. 

 

	 	(c)	 No consent, approval, authorization, or order of, or filing with, any governmental agency or body or any court
is required in connection with the execution, delivery or performance by Counterparty of this Confirmation, except such as have been obtained or made and such as may be required under the Securities Act or state securities laws.

  

	 	(d)	 Counterparty is not and, after consummation of the Transaction, will not be required to register as an
“investment company” as such term is defined in the Investment Company Act of 1940, as amended. 

  

	 	(e)	 Counterparty is an “eligible contract participant” (as such term is defined in Section 1a(18) of
the Commodity Exchange Act, as amended, other than a person that is an eligible contract participant under Section 1a(18)(C) of the Commodity Exchange Act). 

 

	 	(f)	 Each of it and its affiliates is not, on the date hereof, in possession of any material non-public information with respect to Counterparty or the Shares. 

  

	 	(g)	 No state or local (including any non-U.S. jurisdiction’s) law,
rule, regulation or regulatory order applicable to the Shares would give rise to any reporting, consent, registration or other requirement (including without limitation a requirement to obtain prior approval from any person or entity) as a result of
Dealer or its affiliates owning or holding (however defined) Shares. 

  

	 	(h)	 Counterparty (A) is capable of evaluating investment risks independently, both in general and with regard
to all transactions and investment strategies involving a security or securities; (B) will exercise independent judgment in evaluating the recommendations of any broker-dealer or its associated persons, unless it has otherwise notified the
broker-dealer in writing; and (C) has total assets of at least USD 50 million. 

  

	 	(i)	 The assets of Counterparty do not constitute “plan assets” under the Employee Retirement Income
Security Act of 1974, as amended, the Department of Labor Regulations promulgated thereunder or similar law. 

  

	9.	 Other Provisions. 

 

	 	(a)	 Opinions. Counterparty shall deliver to Dealer an opinion of counsel, dated as of the Premium
Payment Date, with respect to the matters set forth in Sections 8(a) through (c) of this Confirmation. Delivery of such opinion to Dealer shall be a condition precedent for the purpose of Section 2(a)(iii) of the Agreement with respect to
each obligation of Dealer under Section 2(a)(i) of the Agreement. 

  
 15 

	 	(b)	 Repurchase Notices. Counterparty shall, on any day on which Counterparty effects any repurchase
of Shares, promptly give Dealer a written notice of such repurchase (a “Repurchase Notice”) on such day if following such repurchase, the number of outstanding Shares as determined on such day is (i) less
than 155.0 million (in the case of the first such notice) or (ii) thereafter more than 6.8 million less than the number of Shares included in the immediately preceding Repurchase Notice. Counterparty agrees to indemnify and hold
harmless Dealer and its affiliates and their respective officers, directors, employees, affiliates, advisors, agents and controlling persons (each, an “Indemnified Person”) from and against any and all losses
(including losses relating to Dealer’s commercially reasonable hedging activities as a consequence of becoming, or of the risk of becoming, a Section 16 “insider”, including without limitation, any forbearance from hedging
activities or cessation of hedging activities and any losses in connection therewith with respect to the Transaction), claims, damages, judgments, liabilities and expenses (including reasonable attorney’s fees), joint or several, which an
Indemnified Person may become subject to, as a result of Counterparty’s failure to provide Dealer with a Repurchase Notice on the day and in the manner specified in this paragraph, and to reimburse, within 30 days, upon written request, each of
such Indemnified Persons for any reasonable legal or other expenses incurred in connection with investigating, preparing for, providing testimony or other evidence in connection with or defending any of the foregoing. If any suit, action, proceeding
(including any governmental or regulatory investigation), claim or demand shall be brought or asserted against the Indemnified Person as a result of Counterparty’s failure to provide Dealer with a Repurchase Notice in accordance with this
paragraph, such Indemnified Person shall promptly notify Counterparty in writing, and Counterparty, upon request of the Indemnified Person, shall retain counsel reasonably satisfactory to the Indemnified Person to represent the Indemnified Person
and any others Counterparty may designate in such proceeding and shall pay the reasonable fees and expenses of such counsel related to such proceeding. Counterparty shall not be liable for any settlement of any proceeding contemplated by this
paragraph that is effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, Counterparty agrees to indemnify any Indemnified Person from and against any loss or liability by reason of
such settlement or judgment. Counterparty shall not, without the prior written consent of the Indemnified Person, effect any settlement of any pending or threatened proceeding contemplated by this paragraph that is in respect of which any
Indemnified Person is or could have been a party and indemnity could have been sought hereunder by such Indemnified Person, unless such settlement includes an unconditional release of such Indemnified Person from all liability on claims that are the
subject matter of such proceeding on terms reasonably satisfactory to such Indemnified Person. If the indemnification provided for in this paragraph is unavailable to an Indemnified Person or insufficient in respect of any losses, claims, damages or
liabilities referred to therein, then Counterparty hereunder, in lieu of indemnifying such Indemnified Person thereunder, shall contribute to the amount paid or payable by such Indemnified Person as a result of such losses, claims, damages or
liabilities. The remedies provided for in this paragraph (b) are not exclusive and shall not limit any rights or remedies which may otherwise be available to any Indemnified Person at law or in equity. The indemnity and contribution agreements
contained in this paragraph shall remain operative and in full force and effect regardless of the termination of the Transaction. 

  

	 	(c)	 Regulation M. Counterparty is not on the Trade Date engaged in a distribution, as such term is
used in Regulation M under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), of any securities of Counterparty, other than a distribution meeting the requirements of the exception set forth
in Rules 101(b)(10) and 102(b)(7) of Regulation M. Counterparty shall not, until the second Scheduled Trading Day immediately following the Effective Date, engage in any such distribution. 

 

	 	(d)	 No Manipulation. Counterparty is not entering into the Transaction to create actual or apparent
trading activity in the Shares (or any security convertible into or exchangeable for the Shares) or to raise or depress or otherwise manipulate the price of the Shares (or any security convertible into or exchangeable for the Shares) or otherwise in
violation of the Exchange Act. 

  
 16 

	 	(e)	 Transfer or Assignment.

 

	 	(i)	 Counterparty shall have the right to transfer or assign its rights and obligations hereunder with respect to
all, but not less than all, of the Options hereunder (such Options, the “Transfer Options”); provided that such transfer or assignment shall be subject to reasonable conditions that Dealer may impose,
including but not limited, to the following conditions: 

  

	 	(A)	 With respect to any Transfer Options, Counterparty shall not be released from its notice and indemnification
obligations pursuant to Section 9(b) or any obligations under Section 9(n) or 9(s) of this Confirmation; 

  

	 	(B)	 Any Transfer Options shall only be transferred or assigned to a third party that is a United States person (as
defined in the Internal Revenue Code of 1986, as amended); 

  

	 	(C)	 Such transfer or assignment shall be effected on terms, including any reasonable undertakings by such third
party (including, but not limited to, an undertaking with respect to compliance with applicable securities laws in a manner that, in the reasonable judgment of Dealer, will not expose Dealer to material risks under applicable securities laws) and
execution of any documentation and delivery of legal opinions with respect to securities laws and other matters by such third party and Counterparty, as are requested and reasonably satisfactory to Dealer; 

 

	 	(D)	 Dealer will not, as a result of such transfer and assignment, be required to pay the transferee on any payment
date an amount under Section 2(d)(i)(4) of the Agreement greater than an amount that Dealer would have been required to pay to Counterparty in the absence of such transfer and assignment; 

 

	 	(E)	 An Event of Default, Potential Event of Default or Termination Event will not occur as a result of such
transfer and assignment; 

  

	 	(F)	 Without limiting the generality of clause (B), Counterparty shall cause the transferee to make such Payee Tax
Representations and to provide such tax documentation as may be reasonably requested by Dealer to permit Dealer to determine that results described in clauses (D) and (E) will not occur upon or after such transfer and assignment; and

  

	 	(G)	 Counterparty shall be responsible for all reasonable costs and expenses, including reasonable counsel fees,
incurred by Dealer in connection with such transfer or assignment. 

  

	 	(ii)	 Dealer may, without Counterparty’s consent, transfer or assign all or any part of its rights or
obligations under the Transaction to any affiliate of Dealer (1) that has a long-term issuer rating that is equal to or better than Dealer’s credit rating at the time of such transfer or assignment, or (2) whose obligations hereunder
will be guaranteed, pursuant to the terms of a customary guarantee in a form used by Dealer generally for similar transactions, by Dealer or Dealer’s ultimate parent. If at any time at which (A) the Section 16 Percentage exceeds 9.0%,
(B) the Option Equity Percentage exceeds 14.5%, or (C) the Share Amount exceeds the Applicable Share Limit (if any applies) (any such condition described in clauses (A), (B) or (C), an “Excess Ownership Position”), Dealer is
unable after using its commercially reasonable efforts to effect a transfer or assignment of Options to a third party on pricing terms reasonably acceptable to Dealer and within a time period reasonably acceptable to Dealer such that no Excess
Ownership Position exists, then Dealer may designate any Exchange Business Day as an Early Termination Date with respect to a portion of the Transaction (the “Terminated Portion”), such that following such partial termination no
Excess Ownership Position exists. In the event that Dealer so designates an Early Termination Date with respect to a portion of the Transaction, a payment shall be made pursuant to Section 6 of the Agreement as if (1) an Early Termination
Date had been designated in respect of a Transaction having terms identical to the Transaction and a Number of Options equal to the number of Options underlying the Terminated Portion, (2) Counterparty were the sole Affected Party with respect
to such partial termination and (3) the Terminated Portion were the sole Affected 

  
 17 

	 	Transaction (and, for the avoidance of doubt, the provisions of Section 9(l) shall apply to any amount that is payable by Dealer to Counterparty pursuant to this sentence as if Counterparty was not the Affected
Party). The “Section 16 Percentage” as of any day is the fraction, expressed as a percentage, (A) the numerator of which is the number of Shares that Dealer and any of its affiliates or any other person
subject to aggregation with Dealer for purposes of the “beneficial ownership” test under Section 13 of the Exchange Act, or any “group” (within the meaning of Section 13 of the Exchange Act) of which Dealer is or may be
deemed to be a part beneficially owns (within the meaning of Section 13 of the Exchange Act), without duplication, on such day (or, to the extent that for any reason the equivalent calculation under Section 16 of the Exchange Act and the
rules and regulations thereunder results in a higher number, such higher number) and (B) the denominator of which is the number of Shares outstanding on such day. The “Option Equity Percentage” as of any day is the fraction,
expressed as a percentage, (A) the numerator of which is the sum of (1) the product of the Number of Options and the Option Entitlement and (2) the aggregate number of Shares underlying any other call option transaction sold by Dealer
to Counterparty, and (B) the denominator of which is the number of Shares outstanding. The “Share Amount” as of any day is the number of Shares that Dealer and any person whose ownership position would be aggregated with that
of Dealer (Dealer or any such person, a “Dealer Person”) under any law, rule, regulation, regulatory order or organizational documents or contracts of Counterparty that are, in each case, applicable to ownership of Shares
(“Applicable Restrictions”), owns, beneficially owns, constructively owns, controls, holds the power to vote or otherwise meets a relevant definition of ownership under any Applicable Restriction, as determined by Dealer in its
reasonable discretion. The “Applicable Share Limit” means a number of Shares equal to (A) the minimum number of Shares that could give rise to reporting or registration obligations or other requirements (including obtaining
prior approval from any person or entity but excluding any filings of Form 13F, Schedule 13D or Schedule 13G under the Exchange Act, in each case, as in effect on the Trade Date) of a Dealer Person, or could result in an adverse effect on a Dealer
Person, under any Applicable Restriction, as determined by Dealer in its reasonable discretion, minus (B) 1% of the number of Shares outstanding. 

  

	 	(iii)	 Notwithstanding any other provision in this Confirmation to the contrary requiring or allowing Dealer to
purchase, sell, receive or deliver any Shares or other securities, or make or receive any payment in cash, to or from Counterparty, Dealer may designate any of its affiliates to purchase, sell, receive or deliver such Shares or other securities, or
to make or receive such payment in cash, and otherwise to perform Dealer’s obligations in respect of the Transaction and any such designee may assume such obligations. Dealer shall be discharged of its obligations to Counterparty to the extent
of any such performance. 

  

	 	(f)	 Staggered Settlement. If upon advice of counsel with respect to applicable legal and regulatory
requirements, including any requirements relating to Dealer’s commercially reasonable hedging activities hereunder, Dealer reasonably determines that it would not be practicable or advisable to deliver, or to acquire Shares to deliver, any or
all of the Shares to be delivered by Dealer on any Settlement Date for the Transaction, Dealer may, by notice to Counterparty on or prior to such Settlement Date (a “Nominal Settlement Date”), elect to deliver the Shares on two or
more dates (each, a “Staggered Settlement Date”) or at two or more times on the Nominal Settlement Date as follows: 

  

	 	(i)	 in such notice, Dealer will specify to Counterparty the related Staggered Settlement Dates (each of which will
be on or prior to such Nominal Settlement Date, but not prior to the beginning of the Settlement Averaging Period or, if applicable, any other date of valuation) or delivery times and how it will allocate the Shares it is required to deliver among
the Staggered Settlement Dates or delivery times; and 

  

	 	(ii)	 the aggregate number of Shares that Dealer will deliver to Counterparty hereunder on all such Staggered
Settlement Dates and delivery times will equal the number of Shares that Dealer would otherwise be required to deliver on such Nominal Settlement Date. 

  
 18 

	 	(g)	 Method of Delivery. Whenever delivery of funds or other assets is required hereunder by or to
Counterparty, such delivery shall be effected through DBSI. In addition, all notices, demands and communications of any kind relating to the Transaction between Dealer and Counterparty shall be transmitted exclusively through DBSI. 

  

	 	(h)	 [Reserved.]  

 

	 	(i)	 Additional Termination Events.

 

	 	(i)	 Notwithstanding anything to the contrary in this Confirmation, upon any Early Conversion or Make-Whole
Conversion in respect of which a Notice of Conversion that is effective as to Counterparty has been delivered by the relevant converting Holder: 

  

	 	(A)	 Counterparty shall, within one Scheduled Trading Day of the Conversion Date for such Early Conversion or
Make-Whole Conversion, as the case may be, provide written notice (an “Early/Make-Whole Conversion Notice”) to Dealer specifying the number of Convertible Notes surrendered for conversion on such Conversion Date (such
Convertible Notes, the “Affected Convertible Notes”), and the giving of such Early/Make-Whole Conversion Notice shall constitute an Additional Termination Event as provided in this clause (i); 

 

	 	(B)	 upon receipt of any such Early/Make-Whole Conversion Notice, Dealer shall designate an Exchange Business Day as
an Early Termination Date (which Exchange Business Day shall be no earlier than one Scheduled Trading Day following the Conversion Date for such Early Conversion or Make-Whole Conversion, as applicable) with respect to the portion of the Transaction
corresponding to a number of Options (the “Affected Number of Options”) equal to the lesser of (x) the number of Affected Convertible Notes and (y) the Number of Options as of the Conversion Date for such
Early Conversion or Make-Whole Conversion, as applicable; 

  

	 	(C)	 any payment hereunder with respect to such termination shall be calculated pursuant to Section 6 of the
Agreement as if (x) an Early Termination Date had been designated in respect of a Transaction having terms identical to the Transaction and a Number of Options equal to the Affected Number of Options, (y) Counterparty were the sole
Affected Party with respect to such Additional Termination Event and (z) the terminated portion of the Transaction were the sole Affected Transaction; provided that the amount payable with respect to such termination shall not be greater
than the Applicable Percentage multiplied by (x) the sum of (i) the amount of cash paid (if any) to the Holder (as such term is defined in the Indenture) of an Affected Convertible Note upon conversion of such Affected Convertible
Note and (ii) the number of Shares delivered (if any) to the Holder (as such term is defined in the Indenture) of an Affected Convertible Note upon conversion of such Affected Convertible Note, multiplied by the fair market value of one
Share as determined by the Calculation Agent, minus (y) USD 1,000; 

  

	 	(D)	 for the avoidance of doubt, in determining the amount payable in respect of such Affected Transaction pursuant
to Section 6 of the Agreement, the Calculation Agent shall assume that (x) the relevant Early Conversion or Make-Whole Conversion, as the case may be, and any conversions, adjustments, agreements, payments, deliveries or acquisitions by or
on behalf of Counterparty leading thereto had not occurred, (y) no adjustments to the Conversion Rate have occurred pursuant to any Excluded Provision and (z) the corresponding Convertible Notes remain outstanding; and

  

	 	(E)	 the Transaction shall remain in full force and effect, except that, as of the Conversion Date for such Early
Conversion or Make-Whole Conversion, as applicable, the Number of Options shall be reduced by the Affected Number of Options. 

  
 19 

	 	(ii)	 Notwithstanding anything to the contrary in this Confirmation if an event of default with respect to
Counterparty occurs under the terms of the Convertible Notes as set forth in Section 6.01 of the Indenture that results in the acceleration of Counterparty’s payment obligations under the Convertible Notes pursuant to the terms of the
Indenture, then such acceleration shall constitute an Additional Termination Event applicable to the Transaction and, with respect to such Additional Termination Event, (A) Counterparty shall be deemed to be the sole Affected Party,
(B) the Transaction shall be the sole Affected Transaction and (C) Dealer shall be the party entitled to designate an Early Termination Date pursuant to Section 6(b) of the Agreement. 

 

	 	(iii)	 Notwithstanding anything to the contrary in this Confirmation, the occurrence of an Amendment Event shall
constitute an Additional Termination Event applicable to the Transaction and, with respect to such Additional Termination Event, (A) Counterparty shall be deemed to be the sole Affected Party, (B) the Transaction shall be the sole Affected
Transaction and (C) Dealer shall be the party entitled to designate an Early Termination Date pursuant to Section 6(b) of the Agreement. “Amendment Event” means that Counterparty amends, modifies,
supplements, waives or obtains a waiver in respect of any term of the Indenture or the Convertible Notes governing the principal amount, coupon, maturity, repurchase obligation of Counterparty, any term relating to conversion of the Convertible
Notes (including changes to the conversion rate, conversion rate adjustment provisions, conversion settlement dates or conversion conditions), or any term that would require consent of the holders of not less than 100% of the principal amount of the
Convertible Notes to amend (other than, in each case, any amendment or supplement (x) pursuant to Section 10.01(h) of the Indenture that, as determined by the Calculation Agent, conforms the Indenture to the description of Convertible
Notes in the Offering Memorandum or (y) pursuant to Section 14.07 of the Indenture), in each case, without the consent of Dealer. 

  

	 	(j)	 Amendments to Equity Definitions.

 

	 	(i)	 Section 11.2(e)(vii) of the Equity Definitions is hereby amended by deleting the words “a diluting or
concentrative” and replacing them with the words “a material” and adding the phrase “or the Options” at the end of the sentence. 

  

	 	(ii)	 Section 12.6(a)(ii) of the Equity Definitions is hereby amended by (1) inserting “(1)”
immediately following the word “means” in the first line thereof and (2) inserting immediately prior to the semi-colon at the end of subsection (B) thereof the following words: “or (2) the occurrence of any of the
events specified in Section 5(a)(vii)(1) through (9) of the ISDA Master Agreement with respect to that Issuer”. 

  

	 	(iii)	 Section 12.9(b)(i) of the Equity Definitions is hereby amended by (1) replacing “either party
may elect” with “Dealer may elect” and (2) replacing “notice to the other party” with “notice to Counterparty” in the first sentence of such section. 

 

	 	(iv)	 Section 12.9(b)(vi) of the Equity Definitions is hereby amended by (1) adding the word “or”
immediately before subsection “(B)”, (2) deleting the comma at the end of subsection (A), (3) deleting subsection (C) in its entirety, (4) deleting the word “or” immediately preceding subsection (C) and (5)
replacing the words “either party” in the last sentence of such Section with “the Hedging Party”. 

  

	 	(k)	 Setoff. Each party waives any and all rights it may have to setoff, whether arising under any
agreement, applicable law or otherwise.  

  

	 	(l)	 Alternative Calculations and Payment on Early Termination and on Certain Extraordinary Events. If
(a) an Early Termination Date (whether as a result of an Event of Default or a Termination Event) occurs or is designated with respect to the Transaction or (b) the Transaction

  
 20 

	 	
is cancelled or terminated upon the occurrence of an Extraordinary Event (except as a result of (i) a Nationalization, Insolvency or Merger Event in which the consideration to be paid to
holders of Shares consists solely of cash, (ii) an Announcement Event, Merger Event or Tender Offer that is within Counterparty’s control, or (iii) an Event of Default in which Counterparty is the Defaulting Party or a Termination
Event in which Counterparty is the Affected Party other than an Event of Default of the type described in Section 5(a)(iii), (v), (vi), (vii) or (viii) of the Agreement or a Termination Event of the type described in Section 5(b) of
the Agreement, in each case that resulted from an event or events outside Counterparty’s control), and if Dealer would owe any amount to Counterparty pursuant to Section 6(d)(ii) of the Agreement or any Cancellation Amount pursuant to
Article 12 of the Equity Definitions (any such amount, a “Payment Obligation”), then Dealer shall satisfy the Payment Obligation by the Share Termination Alternative (as defined below), unless (a) Counterparty
gives irrevocable telephonic notice to Dealer, confirmed in writing within one Scheduled Trading Day, no later than 12:00 p.m. (New York City time) on the date of the Announcement Event, Merger Date, Tender Offer Date, Announcement Date (in the case
of a Nationalization, Insolvency or Delisting), Early Termination Date or date of cancellation, as applicable, of its election that the Share Termination Alternative shall not apply, (b) Counterparty remakes the representation set forth in
Section 8(f) as of the date of such election and (c) Dealer agrees to such election, in which case the provisions of Section 12.7 or Section 12.9 of the Equity Definitions, or the provisions of Section 6(d)(ii) of the
Agreement, as the case may be, shall apply. 

  

			
	 Share Termination Alternative:
	  	If applicable, Dealer shall deliver to Counterparty the Share Termination Delivery Property on, or within a commercially reasonable period of time after, the date when the relevant Payment Obligation would otherwise be due pursuant
to Section 12.7 or 12.9 of the Equity Definitions or Section 6(d)(ii) and 6(e) of the Agreement, as applicable, in satisfaction of such Payment Obligation in the manner reasonably requested by Counterparty free of payment.
		
	 Share Termination Delivery Property:
	  	A number of Share Termination Delivery Units, as calculated by the Calculation Agent, equal to the Payment Obligation divided by the Share Termination Unit Price. The Calculation Agent shall adjust the Share Termination Delivery
Property by replacing any fractional portion of a security therein with an amount of cash equal to the value of such fractional security based on the values used to calculate the Share Termination Unit Price.
		
	 Share Termination Unit Price:
	  	The value to Dealer of property contained in one Share Termination Delivery Unit, as determined by the Calculation Agent in its good faith discretion by commercially reasonable means and notified by the Calculation Agent to Dealer
at the time of notification of the Payment Obligation. For the avoidance of doubt, the parties agree that in determining the Share Termination Delivery Unit Price the Calculation Agent may consider the purchase price paid in connection with the
purchase of Share Termination Delivery Property.
		
	 Share Termination Delivery Unit:
	  	One Share or, if the Shares have changed into cash or any other property or the right to receive cash or any other property as the result of a Nationalization, Insolvency or Merger Event (any such cash or other property, the
“Exchange Property”), a unit consisting of the type and amount of such Exchange Property received by a holder of one Share (without

  
 21 

			
		
		  	consideration of any requirement to pay cash or other consideration in lieu of fractional amounts of any securities) in such Nationalization, Insolvency or Merger Event, as determined by the Calculation Agent.
		
	 Failure to Deliver:
	  	Applicable
		
	 Other applicable provisions:
	  	If Share Termination Alternative is applicable, the provisions of Sections 9.8, 9.9 and 9.11 (as modified above) of the Equity Definitions and the provisions set forth opposite the caption “Representation and Agreement” in
Section 2 will be applicable, except that all references in such provisions to “Physically-settled” shall be read as references to “Share Termination Settled” and all references to “Shares” shall be read as
references to “Share Termination Delivery Units”. “Share Termination Settled” in relation to the Transaction means that Share Termination Alternative is applicable to the Transaction.

  

	 	(m)	 Waiver of Jury Trial. Each party waives, to the fullest extent permitted by applicable law, any
right it may have to a trial by jury in respect of any suit, action or proceeding relating to the Transaction. Each party (i) certifies that no representative, agent or attorney of either party has represented, expressly or otherwise, that such
other party would not, in the event of such a suit, action or proceeding, seek to enforce the foregoing waiver and (ii) acknowledges that it and the other party have been induced to enter into the Transaction, as applicable, by, among other
things, the mutual waivers and certifications provided herein. 

  

	 	(n)	 Registration. Counterparty hereby agrees that if, in the good faith reasonable judgment of
Dealer, the Shares (“Hedge Shares”) acquired by Dealer for the purpose of hedging its obligations pursuant to the Transaction cannot be sold in the public market by Dealer without registration under the Securities Act,
Counterparty shall, at its election, either (i) in order to allow Dealer to sell the Hedge Shares in a registered offering, make available to Dealer an effective registration statement under the Securities Act and enter into an agreement, in
form and substance satisfactory to Dealer, substantially in the form of an underwriting agreement for a registered secondary offering; provided, however, that if Dealer, in its reasonable discretion, is not satisfied with access to due
diligence materials, the results of its due diligence investigation, or the procedures and documentation for the registered offering referred to above, then clause (ii) or clause (iii) of this paragraph shall apply at the election of
Counterparty, (ii) in order to allow Dealer to sell the Hedge Shares in a private placement, enter into a private placement agreement substantially similar to private placement purchase agreements customary for private placements of equity
securities, in form and substance satisfactory to Dealer (in which case, the Calculation Agent shall make any adjustments to the terms of the Transaction that are necessary, in its reasonable judgment, to compensate Dealer for any discount from the
public market price of the Shares incurred on the sale of Hedge Shares in a private placement), or (iii) purchase the Hedge Shares from Dealer at the then-current market price on such Exchange Business Days, and in the amounts and at such
time(s), reasonably requested by Dealer. 

  

	 	(o)	 Tax Disclosure. Effective from the date of commencement of discussions concerning the
Transaction, Counterparty and each of its employees, representatives, or other agents may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the Transaction and all materials of any kind
(including opinions or other tax analyses) that are provided to Counterparty relating to such tax treatment and tax structure. 

  

	 	(p)	 Right to Extend. Dealer may postpone or add, in whole or in part, any Valid Day or Valid Days
during the Settlement Averaging Period or any other date of valuation, payment or delivery by Dealer, with respect to some or all of the Options hereunder, if Dealer reasonably determines, in

  
 22 

	 	
its discretion, that such action is reasonably necessary or appropriate to preserve Dealer’s commercially reasonable hedging or hedge unwind activity hereunder in light of existing liquidity
conditions or to enable Dealer to effect purchases or sales of Shares in connection with its commercially reasonable hedging, hedge unwind or settlement activity hereunder in a manner that would, if Dealer were Counterparty or an affiliated
purchaser of Counterparty, be in compliance with applicable legal, regulatory or self-regulatory requirements, or with related policies and procedures applicable to Dealer; provided that no such Valid Day or other date of valuation, payment
or delivery may be postponed or added more than 50 Valid Days after the final day in the original Settlement Averaging Period or original other date of valuation, payment or delivery, as the case may be. 

 

	 	(q)	 Status of Claims in Bankruptcy. Dealer acknowledges and agrees that this Confirmation is not
intended to convey to Dealer rights against Counterparty with respect to the Transaction that are senior to the claims of common stockholders of Counterparty in any United States bankruptcy proceedings of Counterparty; provided that nothing
herein shall limit or shall be deemed to limit Dealer’s right to pursue remedies in the event of a breach by Counterparty of its obligations and agreements with respect to the Transaction; provided, further that nothing herein
shall limit or shall be deemed to limit Dealer’s rights in respect of any transactions other than the Transaction. 

  

	 	(r)	 Securities Contract; Swap Agreement. The parties hereto intend for (i) the Transaction to be
a “securities contract” and a “swap agreement” as defined in the Bankruptcy Code (Title 11 of the United States Code) (the “Bankruptcy Code”), and the parties hereto to be entitled to the protections afforded by,
among other Sections, Sections 362(b)(6), 362(b)(17), 546(e), 546(g), 555 and 560 of the Bankruptcy Code, (ii) a party’s right to liquidate the Transaction and to exercise any other remedies upon the occurrence of any Event of Default
under the Agreement with respect to the other party to constitute a “contractual right” as described in the Bankruptcy Code, and (iii) each payment and delivery of cash, securities or other property hereunder to constitute a
“margin payment” or “settlement payment” and a “transfer” as defined in the Bankruptcy Code. 

  

	 	(s)	 Notice of Certain Other Events. Counterparty covenants and agrees that: 

 

	 	(i)	 promptly following the public announcement of the results of any election by the holders of Shares with respect
to the consideration due upon consummation of any Merger Event, Counterparty shall give Dealer written notice of the weighted average of the types and amounts of consideration received by holders of Shares upon consummation of such Merger Event (the
date of such notification, the “Consideration Notification Date”); provided that in no event shall the Consideration Notification Date be later than the date on which such Merger Event is consummated; and

  

	 	(ii)	 (A) Counterparty shall give Dealer commercially reasonable advance (but in any event at least one Exchange
Business Day prior to the relevant Adjustment Notice Deadline) written notice of the section or sections of the Indenture and, if applicable, the formula therein, pursuant to which any adjustment will be made to the Convertible Notes in connection
with any Potential Adjustment Event (other than a Potential Adjustment Event in respect of the Dilution Adjustment Provision set forth in Section 14.04(b) or Section 14.04(d) of the Indenture) or Merger Event and (B) promptly
following any such adjustment, or any adjustment in respect of the Dilution Adjustment Provision set forth in Section 14.04(b) or Section 14.04(d) of the Indenture, Counterparty shall give Dealer written notice of the details of such
adjustment. The “Adjustment Notice Deadline” means (i) for any Potential Adjustment Event in respect of the Dilution Adjustment Provision set forth in Section 14.04(a) of the Indenture, the relevant Ex-Dividend Date (as such term is defined in the Indenture) or Effective Date (as such term is defined in the Indenture), as the case may be, (ii) for any Potential Adjustment Event in respect of the Dilution
Adjustment Provision in the first formula set forth in Section 14.04(c) of the Indenture, the first Trading Day (as such term is defined in the Indenture) of the period referred to in the definition of “SP0” in such formula, (iii) for any Potential Adjustment Event in respect of the Dilution Adjustment Provision in the second formula set forth in Section 14.04(c) of the Indenture, the
first Trading Day (as such term is defined in the Indenture) of the Valuation Period (as such term is defined in the Indenture), (iv) for any 

  
 23 

	 	Potential Adjustment Event in respect of the Dilution Adjustment Provision set forth in Section 14.04(e) of the Indenture, the first Trading Day (as such term is defined in the Indenture) of the period referred to
in the definition of “SP’” in the formula in such Section, and (v) for any Merger Event, the effective date of such Merger Event (or, if earlier, the first day of any valuation or similar period in respect of such Merger Event).

  

	 	(t)	 Wall Street Transparency and Accountability Act. In connection with Section 739 of the Wall
Street Transparency and Accountability Act of 2010 (“WSTAA”), the parties hereby agree that neither the enactment of WSTAA or any regulation under the WSTAA, nor any requirement under WSTAA or an amendment made by WSTAA, shall limit
or otherwise impair either party’s otherwise applicable rights to terminate, renegotiate, modify, amend or supplement this Confirmation or the Agreement, as applicable, arising from a termination event, force majeure, illegality, increased
costs, regulatory change or similar event under this Confirmation, the Equity Definitions incorporated herein, or the Agreement (including, but not limited to, rights arising from Change in Law, Hedging Disruption, Increased Cost of Hedging, an
Excess Ownership Position, or Illegality (as defined in the Agreement)). 

  

	 	(u)	 Agreements and Acknowledgements Regarding Hedging. Counterparty understands, acknowledges and
agrees that: (A) at any time on and prior to the Expiration Date, Dealer and its affiliates may buy or sell Shares or other securities or buy or sell options or futures contracts or enter into swaps or other derivative securities in order to
adjust its hedge position with respect to the Transaction; (B) Dealer and its affiliates also may be active in the market for Shares other than in connection with hedging activities in relation to the Transaction; (C) Dealer shall make its
own determination as to whether, when or in what manner any hedging or market activities in securities of Issuer shall be conducted and shall do so in a manner that it deems appropriate to hedge its price and market risk with respect to the Relevant
Prices; and (D) any market activities of Dealer and its affiliates with respect to Shares may affect the market price and volatility of Shares, as well as the Relevant Prices, each in a manner that may be adverse to Counterparty.

  

	 	(v)	 Early Unwind. In the event the sale of the “Underwritten Securities” (as defined in the
Purchase Agreement) is not consummated with the Initial Purchasers for any reason, or Counterparty fails to deliver to Dealer opinions of counsel as required pursuant to Section 9(a) of this Confirmation, in each case by 5:00 p.m. (New York
City time) on the Premium Payment Date, or such later date as agreed upon by the parties (the Premium Payment Date or such later date the “Early Unwind Date”), the Transaction shall automatically terminate (the “Early
Unwind”), on the Early Unwind Date and (i) the Transaction and all of the respective rights and obligations of Dealer and Counterparty under the Transaction shall be cancelled and terminated and (ii) each party shall be
released and discharged by the other party from and agrees not to make any claim against the other party with respect to any obligations or liabilities of the other party arising out of and to be performed in connection with the Transaction either
prior to or after the Early Unwind Date; provided that Counterparty shall purchase from Dealer on the Early Unwind Date all Shares purchased by Dealer or one or more of its affiliates in connection with the Transaction at the then prevailing
market price. Each of Dealer and Counterparty represents and acknowledges to the other that, subject to the proviso included in this Section 9(v), upon an Early Unwind, all obligations with respect to the Transaction shall be deemed fully and
finally discharged. 

  

	 	(w)	 Payment by Counterparty. In the event that, following payment of the Premium, (i) an Early
Termination Date occurs or is designated with respect to the Transaction as a result of a Termination Event or an Event of Default (other than an Event of Default arising under Section 5(a)(ii) or 5(a)(iv) of the Agreement) and, as a result,
Counterparty owes to Dealer an amount calculated under Section 6(e) of the Agreement, or (ii) Counterparty owes to Dealer, pursuant to Section 12.7 or Section 12.9 of the Equity Definitions, an amount calculated under
Section 12.8 of the Equity Definitions, such amount shall be deemed to be zero. 

  

	 	(x)	 Other Adjustments Pursuant to the Equity Definitions. Notwithstanding anything to the contrary in
this Confirmation, solely for the purpose of adjusting the Cap Price, the terms “Potential Adjustment Event,” “Merger Event,” and “Tender Offer” shall each have the meanings assigned to such term in the Equity
Definitions (as amended by Section 9(j)(i)), and upon the occurrence of a Merger Date, the occurrence of a Tender Offer Date, or declaration by Counterparty of the terms 

  
 24 

	 	of any Potential Adjustment Event, respectively, as such terms are defined in the Equity Definitions, the Calculation Agent shall adjust the Cap Price to maintain the fair value of the Options to Dealer; provided
that in no event shall the Cap Price be less than the Strike Price. For the avoidance of doubt, any adjustment pursuant to this Section 9(x) shall not be duplicative of any other adjustment made pursuant to this Confirmation, including
without limitation pursuant to “Consequences of Announcement Events” in Section 3 of this Confirmation. 

  

	 	(y)	 Determinations. Dealer (including, without limitation, in its capacity as Calculation Agent)
shall deliver to Counterparty, within five Exchange Business Days after a written request by Counterparty, a written explanation describing in reasonable detail any calculation, adjustment or determination made by it (including the methodology,
interest rates, quotations, market data (including volatility) and information from internal sources used in making such calculation, adjustment or determination, but without disclosing Dealer’s proprietary or confidential models or other
information that is proprietary, confidential or otherwise subject to contractual, legal or regulatory obligations to not disclose such information). 

  

	 	(z)	 Tax Forms. For the purposes of Sections 4(a)(i) and (ii) of the Agreement, Counterparty
agrees to deliver to Dealer one duly executed and completed United States Internal Revenue Service Form W-9 (or successor thereto). Such forms or documents shall be delivered upon (i) execution of this
Confirmation and (ii) reasonable request of Dealer. Counterparty agrees that if any form previously delivered has expired or become obsolete or inaccurate in any respect, it shall update such form or certification or promptly notify Dealer in
writing of its inability to do so. 

  

	 	(aa)	 Withholding Tax Imposed on Payments to non-US Counterparties
under the United States Foreign Account Tax Compliance Act. “Indemnifiable Tax”, as defined in Section 14 of the Agreement, shall not include any U.S. federal withholding tax imposed or collected pursuant to Sections 1471
through 1474 of the U.S. Internal Revenue Code of 1986, as amended (the “Code”), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to Section 1471(b) of the Code, or any
fiscal or regulatory legislation, rules or practices adopted pursuant to any intergovernmental agreement entered into in connection with the implementation of such Sections of the Code (a “FATCA Withholding Tax”). For the avoidance
of doubt, a FATCA Withholding Tax is a Tax the deduction or withholding of which is required by applicable law for the purposes of Section 2(d) of the Agreement. 

 

	 	(bb)	 HIRE Act. “Indemnifiable Tax”, as defined in Section 14 of the Agreement, shall
not include any tax imposed on payments treated as dividends from sources within the United States under Section 871(m) of the Code or any regulations issued thereunder. For the avoidance of doubt, any such tax imposed under Section 871(m)
of the Code is a Tax the deduction or withholding of which is required by applicable law for the purposes of Section 2(d) of the Agreement. 

  

	 	(cc)	 Payee Tax Representations. For the purposes of Section 3(f) of the Agreement:

  

	 	(i)	 Counterparty makes the following representations: 

 

	 	(A)	 It is a “U.S. person” (as that term is used in section
1.1441-4(a)(3)(ii) of United States Treasury Regulations for U.S. federal income tax purposes. 

  

	 	(B)	 It is a corporation for U.S. federal income tax purposes and is organized under the laws of the State of
Delaware and is an exempt recipient under Treasury Regulation Section 1.6049-4(c)(1)(ii)(A). 

  

	 	(dd)	 Resolution Stay Protocol. Subject to the below, the provisions set out in the Attachment to the
ISDA 2015 Universal Resolution Stay Protocol as published by the International Swaps and Derivatives Association on 4 November 2015 (“Protocol”), and any additional Country Annex that has been published from time to time and to
which Counterparty has adhered are, mutadis mutandis, incorporated by reference, into the Agreement as though such provisions and definitions were set out in full herein, with any such conforming changes as are necessary to deal with what
would otherwise be inappropriate or incorrect cross-references. References in the Protocol: 

  
 25 

	 	(i)	 the “Adhering Party” shall be deemed to be references to the parties to the Agreement;

  

	 	(ii)	 the “Adherence Letter” shall be deemed to be references to the Agreement; 

 

	 	(iii)	 the “Implementation Date” shall be deemed to be references to the date of the Agreement; and

  

	 	(iv)	 the Agreement shall be deemed a “Covered Agreement.” 

 

	 	(ee)	 2013 EMIR Portfolio Reconciliation, Dispute Resolution and Disclosure Protocol. The parties agree
that the terms of the 2013 EMIR Portfolio Reconciliation, Dispute Resolution and Disclosure Protocol published by ISDA on July 19, 2013 (“Protocol”) apply to the Agreement as if the parties had adhered to the Protocol without
amendment. In respect of the Attachment to the Protocol, (i) the definition of “Adherence Letter” shall be deemed to be deleted and references to “Adherence Letter” shall be deemed to be to this Section 9(ee) (and
references to “such party’s Adherence Letter” and “its Adherence Letter” shall be read accordingly), (ii) references to “adheres to the Protocol” shall be deemed to be “enters into the Agreement”, (iii)
references to “Protocol Covered Agreement” shall be deemed to be references to the Agreement (and each “Protocol Covered Agreement” shall be read accordingly), and (iv) references to “Implementation Date” shall be
deemed to be references to the date of the Agreement. For the purposes of this Section 9(ee): 

  

	 	(i)	 Dealer is a Portfolio Data Sending Entity and Counterparty is a Portfolio Data Receiving Entity;

  

	 	(ii)	 Dealer and Counterparty may use a Third Party Service Provider, and each of Dealer and Counterparty consents to
such use including the communication of the relevant data in relation to Dealer and Counterparty to such Third Party Service Provider for the purposes of the reconciliation services provided by such entity. 

 

	 	(iii)	 The Local Business Days for such purposes in relation to Dealer are New York, London, Frankfurt, Tokyo and
Singapore and in relation to Counterparty are New York; 

  

	 	(iv)	 The provisions in this paragraph shall survive the termination of the Transaction. 

 

	 	(v)	 The following are the applicable email addresses. 

 

			
	         Portfolio Data:
	  	Dealer:
		  	collateral.disputes@db.com
		
		  	Counterparty:
		  	dennis.olis@allscripts.com;
		  	legal.notice@allscripts.com
		
	         Notice of discrepancy:
	  	Dealer:
		  	collateral.disputes@db.com
		
		  	Counterparty:
		  	dennis.olis@allscripts.com;
		  	legal.notice@allscripts.com
		
	         Dispute Notice:
	  	Dealer:
		  	collateral.disputes@db.com
		
		  	Counterparty:
		  	dennis.olis@allscripts.com;
		  	legal.notice@allscripts.com

  
 26 

	 	(ff)	 NFC Representation Protocol. 

 

	 	(i)	 The parties agree that the provisions set out in the Attachment to the ISDA 2013 EMIR NFC Representation
Protocol published by ISDA on March 8, 2013 (the “NFC Representation Protocol”) shall apply to the Agreement as if each party were an Adhering Party under the terms of the NFC Representation Protocol. In respect
of the Attachment to the Protocol, (i) the definition of “Adherence Letter” shall be deemed to be deleted and references to “Adherence Letter” shall be deemed to be to this Section 9(ff) (and references to “the
relevant Adherence Letter” and “its Adherence Letter” shall be read accordingly), (ii) references to “adheres to the Protocol” shall be deemed to be “enters into the Agreement”, (iii) references to “Covered
Master Agreement” shall be deemed to be references to the Agreement (and each “Covered Master Agreement” shall be read accordingly), and (iv) references to “Implementation Date” shall be deemed to be references to the
date of the Agreement. 

  

	 	(ii)	 Counterparty confirms that it enters into the Agreement as a party making the NFC Representation (as such term
is defined in the NFC Representation Protocol). Counterparty shall promptly notify Dealer of any change to its status as a party making the NFC Representation. 

 

	 	(gg)	 Transaction Reporting—Consent for Disclosure of Information. Notwithstanding anything to the
contrary herein or in the Agreement or any non-disclosure, confidentiality or other agreements entered into between the parties from time to time, each party hereby consents to the Disclosure of information
(the “Reporting Consent”): 

  

	 	(i)	 to the extent required by, or necessary in order to comply with, any applicable law, rule or regulation which
mandates Disclosure of transaction and similar information or to the extent required by, or necessary in order to comply with, any order, request or directive regarding Disclosure of transaction and similar information issued by any relevant
authority or body or agency (“Reporting Requirements”); or 

  

	 	(ii)	 to and between the other party’s head office, branches or affiliates; to any person, agent, third party or
entity who provides services to such other party or its head office, branches or affiliates; to a Market; or to any trade data repository or any systems or services operated by any trade repository or Market, in each case, in connection with such
Reporting Requirements. 

 “Disclosure” means disclosure, reporting, retention, or any action similar or
analogous to any of the aforementioned. 
 “Market” means any exchange, regulated market, clearing house, central clearing
counterparty or multilateral trading facility. 
 Disclosures made pursuant to this Reporting Consent may include, without limitation,
Disclosure of information relating to disputes over transactions between the parties, a party’s identity, and certain transaction and pricing data and may result in such information becoming available to the public or recipients in a
jurisdiction which may have a different level of protection for personal data from that of the relevant party’s home jurisdiction. 

This Reporting Consent shall be deemed to constitute an agreement between the parties with respect to Disclosure in general and shall survive
the termination of this Confirmation. No amendment to or termination of this Reporting Consent shall be effective unless such amendment or termination is made in writing between the parties and specifically refers to this Reporting Consent. 

  
 27 

 Please confirm that the foregoing correctly sets forth the terms of our agreement by sending
to us a letter or telex substantially similar to this facsimile, which letter or telex sets forth the material terms of the Transaction to which this Confirmation relates and indicates your agreement to those terms. Dealer will make the time of
execution of the Transaction available upon request. 
 Dealer is authorised for the conduct of certain activities by the Prudential Regulation Authority.
It is subject to limited regulation by the Financial Conduct Authority and by the Prudential Regulation Authority. 
  

			
	DEUTSCHE BANK AG, LONDON BRANCH

			
		
	By:	 	/s/ Faiz Khan

			
	Name:	 	Faiz Khan
	Title:	 	Managing Director

			
		
	By:	 	/s/ John O’Dowd

			
	Name:	 	John O’Dowd
	Title:	 	Attorney in Fact
	
	 DEUTSCHE BANK SECURITIES INC.,

acting solely as Agent in connection with the Transaction

			
		
	By:	 	/s/ Faiz Khan

			
	Name:	 	Faiz Khan
	Title:	 	Managing Director

			
		
	By:	 	/s/ John O’Dowd

			
	Name:	 	John O’Dowd
	Title:	 	Director

 [Signature Page to Capped Call Confirmation] 

 

			
	 Chairman of the Supervisory Board: Paul Achleitner.

Management Board: Christian Sewing (Chairman), Karl von Rohr, Frank Kuhnke, Stuart Lewis, James von Moltke, Werner Steinmuller.

 
 Deutsche Bank AG is authorised under German Banking Law (competent
authority: European Central Bank and the BaFin, Germany’s Federal Financial Supervisory Authority) and, in the United Kingdom, by the Prudential Regulation Authority. It is subject to supervision by the European Central Bank and by the BaFin,
and is subject to limited regulation in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority.
	  	Deutsche Bank AG is a joint stock corporation with limited liability incorporated in the Federal Republic of Germany, Local Court of Frankfurt am Main, HRB No. 30 000; Branch Registration in
England and Wales BR000005 and Registered Address: Winchester House. 1 Great Winchester Street, London EC2N 2DB. Deutsche Bank AG, London Branch is a member of the London Stock Exchange. (Details about the extent of our authorisation and regulation
in the United Kingdom are available on request or from www.db.com/en/content/eu_disclosures.htm)

			
	Accepted and confirmed as of the Trade Date:
	
	Allscripts Healthcare Solutions, Inc.

			
		
	By:	 	/s/ Dennis M. Olis

			
	Authorized Signatory
	Name: Dennis M. Olis

 [Signature Page to MDRX Capped Call Confirmation]Exhibit 10.1

 

Execution Version

 

EMPLOYMENT AGREEMENT

 

THIS EMPLOYMENT AGREEMENT (this “Agreement”)
is entered into by and between Replimune, Inc. (the “Company”) and Jean Franchi (the “Executive”)
as of November 27, 2019.

 

WHEREAS, the Company desires to employ the
Executive as its Chief Financial Officer, Treasurer, Secretary and Compliance Officer, and the Executive desires to serve in such
capacity on behalf of the Company.

 

NOW, THEREFORE, in consideration of the
premises and of the mutual covenants and agreements hereinafter set forth, the Company and the Executive hereby agree as follows:

 

1.                 Employment.

 

(a)              
Term. The initial term of this Agreement shall begin on December 9, 2019 (the “Effective Date”)
and shall continue for two years, unless the Executive’s employment is sooner terminated in accordance with Sections 6, 7,
8, 9, 10, or 11. Unless earlier terminated, the term of this Agreement shall automatically renew for periods of one year unless
either party gives the other party written notice at least 90 days prior to the end of the then existing term that the term of
this Agreement shall not be further extended. The period commencing on the Effective Date and ending on the date on which the term
of this Agreement terminates is referred to herein as the “Term.”

 

(b)              
Duties. During the Term, the Executive shall serve as the Chief Financial Officer, Treasurer, Secretary and Compliance
Officer of the Company, with duties, responsibilities, and authority commensurate therewith, and shall report to the Executive
Chairman of the Company (the “Chairman”); provided that the Executive may be required to report to the Chief
Executive Officer of the Company (the “CEO”), as determined by the Company in its sole discretion. The Executive
shall perform all duties and accept all responsibilities incident to such position as may be reasonably assigned to the Executive
by the Chairman or the CEO, as applicable. The Executive represents to the Company that the Executive is not subject to or a party
to any employment agreement, noncompetition covenant, or other agreement that would be breached by, or prohibit the Executive from,
executing this Agreement and performing fully the Executive’s duties and responsibilities hereunder.

 

(c)              
Best Efforts. During the Term, the Executive shall devote her best efforts and full time and attention to promote
the business and affairs of the Company and its affiliated entities, and may be engaged in other business activities only to the
extent the Executive has received the prior written consent of the Board of Directors of the Company (the “Board”)
and such activities do not materially interfere or conflict with the Executive’s obligations to the Company hereunder, including,
without limitation, obligations pursuant to Section 15 below. The foregoing shall not be construed as preventing the Executive
from (1) serving on civic, educational, philanthropic or charitable boards or committees and (2) managing personal investments,
so long as such activities are permitted under the Company’s code of conduct and employment policies and do not violate
the provisions of Section 15 below. As of the Effective Date, the Executive is engaged in the business activities set forth on
Exhibit A, which have been approved by the Board.

 

     

     

    

 

(d)              
Principal Place of Employment. The Executive understands and agrees that her principal place of employment will be
in the Company’s offices located in the Boston, MA metropolitan area and that the Executive will be required to travel for
business in the course of performing her duties for the Company.

 

2.                 Compensation.

 

(a)              
Base Salary. During the Term, the Company shall pay the Executive a base salary (“Base Salary”),
at the annual rate of $425,000, which shall be paid in installments in accordance with the Company’s normal payroll practices.
The Executive’s Base Salary shall be reviewed annually by the Chairman or CEO, as applicable, pursuant to the normal performance
review policies for senior-level executives and may be adjusted from time to time as the Compensation Committee of the Board (the
“Compensation Committee”) deems appropriate. The Compensation Committee may take any actions of the Board pursuant
to this Agreement.

 

(b)              
Annual Bonus. The Executive shall be eligible to be awarded an annual discretionary bonus for each fiscal year during
the Term, based on the establishment and attainment of individual and corporate performance goals and targets established by the
Compensation Committee (“Annual Bonus”) in its sole discretion. The target amount of the Executive’s Annual
Bonus for any fiscal year during the Term is 40% of the Executive’s annual Base Salary. Any Annual Bonus awarded shall be
paid after the end of the fiscal year to which it relates, at the same time and under the same terms and conditions as the bonuses
for other executives of the Company; provided that the Executive must be employed in good standing on the date that Executive’s
Annual Bonus is paid. The Annual Bonus shall be subject to the terms of the annual bonus plan that is applicable to other executives
of the Company, including the requirement as to continued employment in good standing, subject to the provisions of Section 7 below.

 

(c)              
Sign-On Bonus. As an inducement for the Executive to join the Company in the role of Chief Financial Officer, Treasurer,
Secretary and Compliance Officer, the Company shall pay the Executive a sign-on bonus in the aggregate amount of $50,000 (the “Sign-On
Bonus”). The Sign-On Bonus will be paid in one lump sum within 30 days following the Effective Date, provided that the
Executive is employed on the payment date. The Sign-On Bonus shall not be for services rendered, but is an incentive payment to
encourage the Executive to commence employment with the Company. As such, the Executive will be required to repay the a prorated
amount of the Sign-On Bonus paid to her if, prior to the first anniversary of the Effective Date, the Executive’s employment
terminates either (1) by the Company for Cause (as defined below), or (2) by the Executive for any reason other than Good Reason
(as defined below). The prorated amount shall be determined by multiplying the Sign-On Bonus by a fraction, the numerator of which
is the days between the Effective Date and the termination date and the denominator of which is 365.

 

    2

     

    

 

(d)              
Stock Option. Subject to the approval of the Compensation Committee, which has already been obtained contingent
on the Executive’s commencement of employment, the Executive will be granted a Nonqualified Stock Option (as defined in
the Replimune Group, Inc. 2018 Omnibus Incentive Compensation Plan (the “Plan”)) to purchase 180,000 shares
(the “Option”), pursuant to the terms of the Company’s Plan and subject to the standard form of Nonqualified
Stock Option Award Agreement under the Plan. Vesting and exercisability of the Option will be over four years from the date of
grant with 25% vesting and becoming exercisable on the first anniversary of the date of grant, and the remainder vesting and becoming
exercisable monthly for three years thereafter.

 

3.                 
Retirement and Welfare Benefits. During the Term, the Executive shall be eligible to participate in the Company’s
health, life insurance, long-term disability, retirement and welfare benefit plans, and programs available to similarly-situated
employees of the Company, pursuant to their respective terms and conditions. Nothing in this Agreement shall preclude the Company
or any Affiliate (as defined below)
of the Company from terminating or amending any employee benefit plan or program from time to time after the Effective Date.

 

4.                 
Paid Time Off. During the Term, the Executive shall be entitled to five weeks of paid time off, in accordance with
the Company’s paid time off policy, as may in effect from time to time. The Executive may use paid time off for vacation,
personal time, or sick time (in accordance with applicable law).

 

5.                 
Business Expenses. The Company shall reimburse the Executive for all necessary and reasonable travel (which does
not include commuting) and other business expenses incurred by the Executive in the performance of her duties hereunder in accordance
with such policies and procedures as the Company may adopt generally from time to time for executives.

 

6.                 
Termination Without Cause; Resignation for Good Reason. The Company may terminate the Executive’s employment
at any time without Cause upon 30 days’ advance written notice. The Executive may initiate a termination of employment by
resigning without Cause or for Good Reason as described below. Upon termination by the Company without Cause or resignation by
the Executive for Good Reason before or after the Change of Control Protection Period (as defined below), if the Executive executes
and does not revoke a written Release (as defined below), the Executive shall be entitled to receive, in lieu of any payments under
any severance plan or program for employees or executives, the following:

 

(a)              
The Company will pay the Executive an amount equal to one times the Executive’s annual Base Salary. Payment shall
be made over the 12-month period following the termination date in installments in accordance with the Company’s normal payroll
practices. Payment will begin within 60 days following the termination date, and any installments not paid between the termination
date and the date of the first payment will be paid with the first payment.

 

(b)              
The Company shall make a lump-sum payment within 60 days following the termination date equal to the COBRA premiums that
the Executive would pay if she elected continued health coverage under the Company’s health plan for the Executive and her
dependents for the 12-month period following the termination date, based on the COBRA rates in effect at the termination date.

 

    3

     

    

 

(c)              
The Company shall pay any other amounts earned, accrued, and owing but not yet paid under Section 2 above and any benefits
accrued and due under any applicable benefit plans and programs of the Company (“Accrued Obligations”), regardless
of whether the Executive executes or revokes the Release.

 

7.                 
Change of Control Termination. Notwithstanding the foregoing, upon termination by the Company without Cause or resignation
by the Executive for Good Reason, in each case on or within 12 months following a Change of Control (as defined in the Plan, or
a successor to the Plan) (the “Change of Control Protection Period”), and provided that the Executive executes
and does not revoke a written Release, then the Executive shall be entitled to receive, in lieu of any payments under Section 6
of this Agreement or any severance plan or program for employees or executives, the following:

 

(a)              
The Company will pay the Executive an amount equal to the sum of (x) the Executive’s annual Base Salary, plus (y)
the Executive’s target Annual Bonus for the year of termination. Payment shall be made over the 12-month period following
the termination date in installments in accordance with the Company’s normal payroll practices. Payment will begin within
60 days following the termination date, and any installments not paid between the termination date and the date of the first payment
will be paid with the first payment.

 

(b)              
The Company shall make a lump-sum payment within 60 days following the termination date equal to the COBRA premiums that
the Executive would pay if she elected continued health coverage under the Company’s health plan for the Executive and her
dependents for the 12-month period following the termination date, based on the COBRA rates in effect at the termination date.

 

(c)              
The Company shall pay any Accrued Obligations, regardless of whether the Executive executes or revokes the Release.

 

8.                 
Cause. The Company may immediately terminate the Executive’s employment at any time for Cause upon written
notice to the Executive, in which event all payments under this Agreement shall cease, except for any Accrued Obligations.

 

9.                 
Voluntary Resignation Without Good Reason. The Executive may voluntarily terminate employment without Good Reason
upon 30 days’ prior written notice to the Company. In such event, after the effective date of such termination, no payments
shall be due under this Agreement, except that the Executive shall be entitled to any Accrued Obligations.

 

10.             
Disability. If the Executive incurs a Disability during the Term, in accordance with applicable law, the Company
may terminate the Executive’s employment on or after the date of Disability. If the Executive’s employment terminates
on account of Disability, the Executive shall be entitled to receive any Accrued Obligations. For purposes of this Agreement, the
term “Disability” shall mean the Executive is eligible to receive long-term disability benefits under the Company’s
long-term disability plan.

 

11.               Death.
If the Executive dies during the Term, the Executive’s employment shall terminate on the date of death and the Company
shall pay any Accrued Obligations to the Executive’s executor, legal representative, administrator or
designated beneficiary, as applicable. Otherwise, the Company shall have no further liability or obligation under this
Agreement to the Executive’s executors, legal representatives, administrators, heirs or assigns or any other person
claiming under or through the Executive.

 

    4

     

    

 

12.             
Resignation of Positions. Effective as of the
date of any termination of employment for any reason, the Executive will be automatically deemed to resign from all Company-related
positions, including as an officer and director of the Company and its parents, subsidiaries and Affiliates, as applicable, and
shall execute all documentation necessary to effectuate such resignation(s).

 

13.             
Definitions. For purposes of this Agreement, the following terms shall have the following meanings:

 

(a)              
“Cause” shall mean a determination by the Board that the Executive (1) has breached this Agreement or
any confidentiality, nonsolicitation, noncompetition or inventions assignment agreement or obligations with the Company; (2) committed
an act of dishonesty, fraud, embezzlement or theft; (3) engaged in conduct that causes, or is likely to cause, material damage
to the property or reputation of the Company; (4) failed to perform satisfactorily the material duties of the Executive’s
position (other than by reason of Disability) after receipt of a written warning from the Board; (5) committed a felony or
any crime of moral turpitude; or (6) materially failed to comply with the Company’s code of conduct or employment policies.

 

(b)              
“Good Reason” shall mean the occurrence of one or more of the following without the Executive’s
consent, other than on account of the Executive’s Disability:

 

(1)              
A material diminution by the Company of the Executive’s authority, duties or responsibilities;

 

(2)              
A material and permanent change in the geographic location at which the Executive must perform services under this Agreement
(which, for purposes of this Agreement, means relocation of the offices of the Company at which the Executive is principally employed
to a location that increases the Executive’s commute to work by more than 50 miles);

 

(3)              
A material diminution in the Executive’s Base Salary, other than a general reduction in Base Salary that affects all
similarly-situated executives in substantially the same proportions;

 

(4)              
Any action or inaction that constitutes a material breach by the Company of this Agreement; or

 

(5)              
The Company elects not to renew the Term of this Agreement pursuant to Section 1(a) above for any reason other than Cause
or Disability and does not offer the Executive continued employment on substantially similar terms as set forth in this Agreement.

 

The Executive must provide written notice
of termination for Good Reason to the Company within 30 days after the event constituting Good Reason. The Company shall have
a period of 30 days in which it may correct the act or failure to act that constitutes the grounds for Good Reason as set forth
in the Executive’s notice of termination. If the Company does not correct the act or failure to act, the Executive’s
employment will terminate for Good Reason on the first business day following the Company’s 30-day cure period. If the Executive
does not provide written notice of termination for Good Reason to the Company within 30 days after an event constituting Good
Reason, then the Executive will be deemed to have waived the Executive’s right to terminate for Good Reason with respect
to such event.

 

    5

     

    

 

(c)              
“Release” shall mean a separation agreement and general release of any and all claims against the Company
and all related parties with respect to all matters arising out of the Executive’s employment by the Company, and the termination
thereof (other than claims for any entitlements under the terms of this Agreement or under any plans or programs of the Company
under which the Executive has accrued and is due a benefit). The Release will be in a standard form determined by and acceptable
to the Company and shall include the Restrictive Covenants set forth in Section 15.

 

14.             
Section 409A.

 

(a)              
This Agreement is intended to comply with section 409A of the Internal Revenue Code of 1986, as amended (the “Code”),
and its corresponding regulations, or an exemption thereto, and payments may only be made under this Agreement upon an event and
in a manner permitted by section 409A of the Code, to the extent applicable. Severance benefits under this Agreement are intended
to be exempt from section 409A of the Code under the “short-term deferral” exception, to the maximum extent applicable,
and then under the “separation pay” exception, to the maximum extent applicable. Notwithstanding anything in this Agreement
to the contrary, if required by section 409A of the Code, if the Executive is considered a “specified employee” for
purposes of section 409A of the Code and if payment of any amounts under this Agreement is required to be delayed for a period
of six months after separation from service pursuant to section 409A of the Code, payment of such amounts shall be delayed as required
by section 409A of the Code, and the accumulated amounts shall be paid in a lump-sum payment within 10 days after the end of the
six-month period. If the Executive dies during the postponement period prior to the payment of benefits, the amounts withheld on
account of section 409A of the Code shall be paid to the personal representative of the Executive’s estate within 60 days
after the date of the Executive’s death.

 

(b)              
All payments to be made upon a termination of employment under this Agreement may only be made upon a “separation
from service” under section 409A of the Code. For purposes of section 409A of the Code, each payment hereunder shall be treated
as a separate payment, and the right to a series of installment payments under this Agreement shall be treated as a right to a
series of separate payments. In no event may the Executive, directly or indirectly, designate the fiscal year of a payment. Notwithstanding
any provision of this Agreement to the contrary, in no event shall the timing of the Executive’s execution of the Release,
directly or indirectly, result in the Executive’s designating the fiscal year of payment of any amounts of deferred compensation
subject to section 409A of the Code, and if a payment that is subject to execution of the Release could be made in more than one
taxable year, payment shall be made in the later taxable year.

 

(c)              
All reimbursements and in-kind benefits provided under this Agreement shall be made or provided in accordance with the
requirements of section 409A of the Code, including, where applicable, the requirement that (i) any reimbursement be for expenses
incurred during the period specified in this Agreement, (ii) the amount of expenses eligible for reimbursement, or in-kind benefits
provided, during a fiscal year not affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any
other fiscal year, (iii) the reimbursement of an eligible expense be made no later than the last day of the fiscal year following
the year in which the expense is incurred, and (iv) the right to reimbursement or in-kind benefits not be subject to liquidation
or exchange for another benefit.

 

    6

     

    

 

15.             
Restrictive Covenants.

 

(a)              
Noncompetition. The Executive agrees that during the Executive’s employment with the Company and its Affiliates
and the one-year period following the date on which the Executive’s employment terminates for any reason (the “Restriction
Period”), the Executive will not, without the Board’s express written consent, engage (directly or indirectly)
in any Competitive Business in the Restricted Area. The term “Competitive Business” means any activities or
services conducted by any third party with respect to the research, development, marketing, manufacturing or sale of oncolytic
immunotherapies that are similar to the activities or services the Executive has performed (or gained Proprietary Information about
(as defined below)) at any time during the last two years of the Executive’s employment with the Company. The term “Restricted
Area” means the United States of America, Canada and countries within Europe, in respect of which the Company or any
of its Affiliates has material business operations as of the date on which the Executive’s employment terminates and in which
the Executive has provided services or had a material presence or influence at any time during the last two years of the Executive’s
employment with the Company or its Affiliates. The Executive agrees that this offer of employment, and the Base Salary provided
for in Section 2(a), the Annual Bonus percentage opportunity provided for in Section 2(b), the separation benefits provided for
in Section 6 and the Change of Control Termination benefits provided for in Section 7, are fair and reasonable consideration for
Executive’s compliance with this Section 15(a). The Executive understands and agrees that, given the nature of the business
of the Company and its Affiliates and the Executive’s position with the Company, the foregoing geographic scope is reasonable
and appropriate and that more limited geographical limitations on this non-competition covenant are therefore not appropriate.
For purposes of this Agreement, the term “Affiliate” means the Company’s sole shareholder, any subsidiary
of the Company or other entity under common control with the Company. The Company shall not enforce this Section 15(a) if it terminates
the Executive’s employment without Cause as defined in Section 13(a).

 

(b)              
Nonsolicitation of Company Personnel. The Executive agrees that during the Restriction Period, the Executive will
not, either directly or through others, hire or attempt to hire any employee, consultant or independent contractor of the Company
or its Affiliates, or solicit or attempt to solicit any such person to change or terminate his or her relationship with the Company
or an Affiliate or otherwise to become an employee, consultant or independent contractor to, for or of any other person or business
entity, unless more than 12 months shall have elapsed between the last day of such person’s employment or service with the
Company or Affiliate and the first day of such solicitation or hiring or attempt to solicit or hire. If any employee, consultant
or independent contractor is hired or solicited by any entity that has hired or agreed to hire the Executive, such hiring or solicitation
shall be conclusively presumed to be a violation of this subsection (b).

 

    7

     

    

 

(c)              
Nonsolicitation of Business Partners. The Executive agrees that during the Restriction Period, the Executive will
not, either directly or through others, solicit, divert or appropriate, or attempt to solicit, divert or appropriate for the benefit
of a Competitive Business, any (1) business partner or (2) prospective business partner of the Company or an Affiliate
who is or was identified through leads developed during the course of the Executive’s employment or service with the Company,
in each case, with whom the Executive was involved as part of the Executive’s job responsibilities during the Executive’s
employment or service with the Company, or regarding whom the Executive learned Proprietary Information (as defined below) during
the Executive’s employment or service with the Company.

 

(d)              
Proprietary Information. At all times, the Executive will hold in strictest confidence and will not disclose, use,
lecture upon or publish any of the Proprietary Information (defined below) of the Company or an Affiliate, except as such disclosure,
use or publication may be required in connection with the Executive’s work for the Company or as described in Section 15(e)
below, or unless the Company expressly authorizes such disclosure in writing. “Proprietary Information” shall
mean any and all confidential and/or proprietary knowledge, data or information of the Company and its Affiliates and shareholders,
including but not limited to information relating to financial matters, investments, budgets, business plans, marketing plans,
personnel matters, business contacts, products, processes, know-how, designs, methods, improvements, discoveries, inventions, ideas,
data, programs, and other works of authorship. Proprietary Information does not include information which (1) was disclosed in
response to a valid order by a court or other governmental body, where the Executive provided the Company with prior written notice
of such disclosure, (2) was or becomes generally available to the public other than as a result of disclosure by the Executive
or any of the Executive’s agents, advisors or representatives, (3) was within the Executive’s possession prior to its
being furnished to the Executive by or on behalf of the Company, provided that the source of the information was not bound by a
confidentiality agreement with the Company or otherwise prohibited from transmitting the information to Executive by a contractual,
legal or fiduciary obligation, or (4) was or becomes available to the Executive on a non-confidential basis from a source other
than the Company or its representatives, provided that such source is not bound by a confidentiality agreement with the Company
or otherwise prohibited from transmitting the information to the Executive by a contractual, legal or fiduciary obligation.

 

(e)              
Reports to Government Entities. Nothing in this Agreement shall prohibit or restrict the Executive from initiating
communications directly with, responding to any inquiry from, providing testimony before, providing confidential information to,
reporting possible violations of law or regulation to, or filing a claim or assisting with an investigation directly with a self-regulatory
authority or a government agency or entity, including the Equal Employment Opportunity Commission, the Department of Labor, the
National Labor Relations Board, the Department of Justice, the Securities and Exchange Commission, Congress, any agency Inspector
General or any other federal, state or local regulatory authority, or from making other disclosures that are protected under the
whistleblower provisions of state or federal law or regulation. The Executive does not need the prior authorization of the Company
to engage in conduct protected by this subsection, and the Executive does not need to notify the Company that the Executive has
engaged in such conduct. Please take notice that federal law provides criminal and civil immunity to federal and state claims
for trade secret misappropriation to individuals who disclose trade secrets to their attorneys, courts, or government officials
in certain, confidential circumstances that are set forth at 18 U.S.C. §§ 1833(b)(1) and 1833(b)(2), related to the
reporting or investigation of a suspected violation of the law, or in connection with a lawsuit for retaliation for reporting
a suspected violation of the law.

 

    8

     

    

 

(f)               
Work Made for Hire; Inventions Assignment. The Executive agrees that all inventions, innovations, improvements, developments,
methods, designs, analyses, reports, and all similar or related information which relates to the Company’s or its Affiliates’
actual or anticipated business, research and development or existing or future products or services and which are conceived, developed
or made by the Executive while employed by the Company (“Work Product”) belong to the Company. The Executive
acknowledges that, by reason of being employed by the Company at the relevant times, to the extent permitted by law, all of the
Work Product consisting of copyrightable subject matter is “work made for hire” as defined in 17 U.S.C. § 101
and such copyrights are therefore owned by the Company. To the extent that the foregoing does not apply, the Executive hereby irrevocably
assigns to the Company, for no additional consideration, the Executive’s entire right, title, and interest in and to all
Work Product and intellectual property rights therein, including, without limitation, the right to sue, counterclaim, and recover
for all past, present, and future infringement, misappropriation, or dilution thereof, and all rights corresponding thereto throughout
the world. The Executive will promptly disclose such Work Product to the Board and perform all actions reasonably requested by
the Board (whether during or after the Term) to establish and confirm such ownership (including, without limitation, executing
assignments, consents, powers of attorney and other instruments). If requested by the Company, the Executive agrees to execute
any inventions assignment and confidentiality agreement that is required to be signed by Company employees generally. Nothing contained
in this Agreement shall be construed to reduce or limit the Company’s rights, title, or interest in any Work Product or intellectual
property rights so as to be less in any respect than that the Company would have had in the absence of this Agreement. The Executive
understands that this Agreement does not, and shall not be construed to, grant the Executive any license or right of any nature
with respect to any Work Product or intellectual property rights or any Proprietary Information, materials, software, or other
tools made available to the Executive by the Company.

 

(g)              
Return of Company Property. Upon termination of the Executive’s
employment with the Company for any reason, and at any earlier time the Company requests, the Executive will (1) deliver to
the person designated by the Company all originals and copies of all documents and property of the Company or an Affiliate that
is in the Executive’s possession or under the Executive’s control or to which the Executive may have access, (2) deliver
to the person designated by the Company all Company property, including keys, key cards, access cards, identification cards, security
devices, employer credit cards, network access devices, computers, cell phones, smartphones, PDAs, pagers, fax machines, equipment,
manuals, reports, files, books, compilations, work product, e-mail messages, recordings, disks, thumb drives or other removable
information storage devices, hard drives, and data, and (3)  to the extent that the Executive made use of the Executive’s
personal electronics (e.g., laptop, iPad, telephone, thumb drives, etc.) during employment with the Company, permit the Company
to delete all Company property and information from such personal devices. The Executive will not reproduce or appropriate for
the Executive’s own use, or for the use of others, any property, Proprietary Information or Work Product.

 

    9

     

    

 

16.             
Legal and Equitable Remedies.

 

(a)              
Because the Executive’s services are personal and unique and
the Executive has had and will continue to have access to and has become and will continue to become acquainted with the
Proprietary Information of the Company and its Affiliates,
and because any breach by the Executive of any of the restrictive covenants contained in Section 15 would result in irreparable
injury and damage for which money damages would not provide an adequate remedy, the Company shall have the right to enforce Section
15 and any of its provisions by injunction, specific performance or other equitable relief, without bond and without prejudice
to any other rights and remedies that the Company may have for a breach, or threatened breach, of the restrictive covenants set
forth in Section 15. The Executive agrees that in any action in which the Company seeks injunction, specific performance or other
equitable relief, the Executive will not assert or contend that any of the provisions of Section 15 are unreasonable or otherwise
unenforceable.

 

(b)              
The Executive irrevocably and unconditionally (1) agrees that any legal proceeding arising out of this Agreement shall be
brought solely in the United States District Court for the District of Massachusetts, or if such court does not have jurisdiction
or will not accept jurisdiction, in any court of general jurisdiction in the State of Massachusetts, (2) consents to the exclusive
jurisdiction of such court in any such proceeding, and (3) waives any objection to the laying of venue of any such proceeding in
any such court. The Executive also irrevocably and unconditionally consents to the service of any process, pleadings, notices or
other papers.

 

(c)              
Notwithstanding anything in this Agreement to the contrary, if the Executive breaches any of the Executive’s obligations
under Section 15, the Company shall be obligated to provide only the Accrued Obligations, and all payments under Section 2, Section
6, or Section 7 hereof, as applicable, shall cease. In such event, and in addition to any legal and equitable remedies permitted
by law, the Company may require that the Executive repay all amounts theretofore paid to her pursuant to Sections 6 and 7 hereof
(other than Sections 6(c) and 7(c)), and in such case, the Executive shall promptly repay such amounts on the terms determined
by the Company.

 

17.             
Survival. The respective rights and obligations of the parties under this Agreement (including, but not limited to,
under Sections 15 and 16) shall survive any termination of the Executive’s employment or termination or expiration of this
Agreement to the extent necessary to the intended preservation of such rights and obligations.

 

18.             
No Mitigation or Set-Off. In no event shall the Executive be obligated to seek other employment or take any other
action by way of mitigation of the amounts payable to the Executive under any of the provisions of this Agreement, and such amounts
shall not be reduced regardless of whether the Executive obtains other employment. The Company’s obligation to make the payments
provided for in this Agreement and otherwise to perform its obligations hereunder shall not be affected by any circumstances, including,
without limitation, any set-off, counterclaim, recoupment, defense or other right which the Company may have against the Executive
or others.

 

    10

     

    

 

19.             
Section 280G. In the event of a change in ownership or control under section 280G of the Code, if it shall be determined
that any payment or distribution in the nature of compensation (within the meaning of section 280G(b)(2) of the Code) to or for
the benefit of the Executive, whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or
otherwise (a “Payment”), would constitute an “excess parachute payment” within the meaning of section
280G of the Code, the aggregate present value of the Payments under the Agreement shall be reduced (but not below zero) to the
Reduced Amount (defined below) if and only if the Accounting Firm (described below) determines that the reduction will provide
the Executive with a greater net after-tax benefit than would no reduction. No reduction shall be made unless the reduction would
provide Executive with a greater net after-tax benefit. The determinations under this Section shall be made as follows:

 

(a)              
The “Reduced Amount” shall be an amount expressed in present value which maximizes the aggregate present
value of Payments under this Agreement without causing any Payment under this Agreement to be subject to the Excise Tax (defined
below), determined in accordance with section 280G(d)(4) of the Code. The term “Excise Tax” means the excise
tax imposed under section 4999 of the Code, together with any interest or penalties imposed with respect to such excise tax.

 

(b)              
Payments under this Agreement shall be reduced on a nondiscretionary basis in such a way as to minimize the reduction in
the economic value deliverable to the Executive. Where more than one payment has the same value for this purpose and they are payable
at different times, they will be reduced on a pro rata basis. Only amounts payable under this Agreement shall be reduced pursuant
to this Section.

 

(c)              
All determinations to be made under this Section shall be made by an independent certified public accounting firm selected
by the Company and agreed to by the Executive immediately prior to the change-in-ownership or -control transaction (the “Accounting
Firm”). The Accounting Firm shall provide its determinations and any supporting calculations both to the Company and
the Executive within 10 days of the transaction. Any such determination by the Accounting Firm shall be binding upon the Company
and the Executive. All of the fees and expenses of the Accounting Firm in performing the determinations referred to in this Section
shall be borne solely by the Company.

 

20.             
Notices. All notices and other communications required or permitted under this Agreement or necessary or convenient
in connection herewith shall be in writing and shall be deemed to have been given when hand-delivered or mailed by registered or
certified mail, as follows (provided that notice of change of address shall be deemed given only when received):

 

If to the Company, to:

 

Replimune Inc.

18 Commerce Way

Woburn, MA 01801

Attn: Executive Chairman

 

with a copy to:

 

Morgan, Lewis & Bockius LLP

One Federal Street

Boston, MA 02110

Attn: Gitte Blanchet

 

    11

     

    

 

If to the Executive, to the most recent
address on file with the Company or to such other names or addresses as the Company or the Executive, as the case may be, shall
designate by notice to each other person entitled to receive notices in the manner specified in this Section.

 

21.             
Withholding. All payments under this Agreement shall be made subject to applicable tax withholding, and the Company
shall withhold from any payments under this Agreement all federal, state, and local taxes as the Company is required to withhold
pursuant to any law or governmental rule or regulation. The Executive shall bear all expense of, and be solely responsible for,
all federal, state, and local taxes due with respect to any payment received under this Agreement.

 

22.             
Remedies Cumulative; No Waiver. No remedy conferred upon a party by this Agreement is intended to be exclusive of
any other remedy, and each and every such remedy shall be cumulative and shall be in addition to any other remedy given under this
Agreement or now or hereafter existing at law or in equity. No delay or omission by a party in exercising any right, remedy or
power under this Agreement or existing at law or in equity shall be construed as a waiver thereof, and any such right, remedy or
power may be exercised by such party from time to time and as often as may be deemed expedient or necessary by such party in its
sole discretion.

 

23.             
Assignment. All of the terms and provisions of this Agreement shall be binding upon and inure to the benefit of and
be enforceable by the respective heirs, executors, administrators, legal representatives, successors, and assigns of the parties
hereto, except that the duties and responsibilities of the Executive under this Agreement are of a personal nature and shall not
be assignable or delegable in whole or in part by the Executive. The Company may assign its rights, together with its obligations
hereunder, in connection with any sale, transfer or other disposition of all or substantially all of its business and assets, and
such rights and obligations shall inure to, and be binding upon, any successor to the business or any successor to substantially
all of the assets of the Company, whether by merger, purchase of stock or assets or otherwise, which successor shall expressly
assume such obligations, and the Executive acknowledges that in such event the obligations of the Executive hereunder, including
but not limited to those under Section 15, will continue to apply in favor of the successor.

 

24.             
Company Policies. This Agreement and the compensation payable hereunder shall be subject to any applicable clawback
or recoupment policies, share trading policies, and other policies that may be implemented by the Board from time to time with
respect to officers of the Company.

 

    12

     

    

 

25.              Indemnification.
In the event the Executive is made, or threatened to be made, a party to any legal action or proceeding, whether civil or
criminal, including any governmental or regulatory proceedings or investigations, by reason of the fact that the Executive is
or was a director or officer of the Company or any of its Affiliates, the Executive shall be indemnified by the Company, and
the Company shall pay the Executive’s related expenses when and as incurred, to the fullest extent permitted by
applicable law and the Company’s articles of incorporation and bylaws. During the Executive’s employment with
the Company or any of its Affiliates and after termination of employment for any reason, the Company shall cover the
Executive under the Company’s directors’ and officers’ insurance policy applicable to other officers and
directors according to the terms of such policy.

 

26.             
Entire Agreement; Amendment. This Agreement sets forth the entire agreement of the parties hereto and supersedes
any and all prior agreements and understandings concerning the Executive’s employment by the Company. This Agreement may
be changed only by a written document signed by the Executive and the Company.

 

27.             
Severability. If any provision of this Agreement or application thereof to anyone or under any circumstances is
adjudicated to be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect any other
provision or application of this Agreement, which can be given effect without the invalid or unenforceable provision or application,
and shall not invalidate or render unenforceable such provision or application in any other jurisdiction. If any provision is
held void, invalid or unenforceable with respect to particular circumstances, it shall nevertheless remain in full force and effect
in all other circumstances.

 

28.             
Governing Law. This Agreement shall be governed by, and construed and enforced in accordance with, the substantive
and procedural laws of Massachusetts without regard to rules governing
conflicts of law.

 

29.             
Acknowledgements. The Executive acknowledges (a) that the Company hereby advises her to consult with legal
counsel prior to signing this Agreement, (b) that she has had a full and adequate opportunity to read and understand the terms
and conditions contained in this Agreement, (c) that she has been provided with this Agreement a minimum of 10 business days prior
to the date this Agreement becomes effective, and (d) that the post-employment noncompetition and nonsolicitation provisions are
supported by fair and reasonable consideration.

 

30.             
Counterparts. This Agreement may be executed in any number of counterparts (including facsimile counterparts), each
of which shall be an original, but all of which together shall constitute one instrument.

 

(Signature Page
Follows)

 

    13

     

    

 

IN WITNESS WHEREOF, the parties hereto have
executed this Agreement as of the day and year first above written.

 

	 	REPLIMUNE,
    INC.
	 	 
	 	/s/
    Philip Astley-Sparke
	 	Name:
    Philip Astley-Sparke
	 	Title:
    Executive Chairman
	 	Date:
    November 27, 2019
	 	 
	 	EXECUTIVE
	 	 
	 	/s/
    Jean Franchi
	 	Name:
    Jean Franchi
	 	 
	 	Date:
    November 27, 2019

 

    14

     

    

 

Exhibit A

 

Biophytis SA (member of the Board of Directors)

 

Visionary Technologies (member of the Board of Directors)

 

Merrimack Pharmaceuticals (consultant pursuant to
a Consulting Agreement dated June 25, 2019)

 

    15

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00302-of-00352.parquet"}]]